Annual Report • Mar 29, 2023
Annual Report
Open in ViewerOpens in native device viewer



Improving the future
of businesses, our partners and people
1 TABLE OF CONTENTS

Registered office: Viale dell'Agricoltura 7, 37135 Verona, Italy Operational headquarters: Via Mecenate 90, 20138 Milan, Italy
Tax code/VAT No. and Verona Companies Register No. 05850710962 An insurance company authorised by ISVAP Order No. 2610 of 3 June 2008 entered in Section I of the Register of Insurance and Reinsurance Companies kept by IVASS, under No. 1.00167; Parent Company of the REVO Insurance group, entered in the IVASS Register of Groups under No. 059
2 TABLE OF CONTENTS

| Corporate officers and Directors 6 | |
|---|---|
| General information 7 | |
| Corporate information 7 | |
| Group structure and scope of consolidation 8 | |
| Group areas of activity 8 | |
| Report on Operations 10 | |
| Market scenario 10 | |
| Industry regulations 12 | |
| Main corporate events 12 | |
| General performance 14 | |
| Performance of insurance operations18 | |
| Evolution of the insurance portfolio and the sales network 19 | |
| Claims 20 | |
| Acquisition expenses and general expenses 22 | |
| Foreign business 23 | |
| Reinsurance policy 23 | |
| Main new products launched on the market24 | |
| Investment policy guidelines and profitability achieved25 | |
| Remuneration policies and employee information 27 | |
| Performance of the Subsidiary 28 | |
| Group summary data for 2022 29 | |
| Solvency II – Solvency margin 29 | |
| Risk management objectives and policy and hedging policy of the companies included in the scope of consolidation 30 | |
| Ongoing disputes 32 | |
| Capital and financial transactions with parent companies, associates, affiliates and other related parties 32 | |
| Other significant events during the year 33 | |
| Main events after year-end 33 | |
| Business outlook 33 | |
| Own shares held and changes in own shares 33 | |
| Relations with public authorities and other entities 34 | |
| Report on corporate governance and ownership structure pursuant to Article 123-bis of Legislative Decree No. 58 of 24 February 1998 34 |
|
| Consolidated financial statements 36 | |
| Statement of financial position 37 | |
| Income statement 39 | |
| Statement of comprehensive income 40 | |
| Statement of changes in shareholders' equity 41 | |
| Statement of cash flows (indirect method) 42 | |
| Notes to the financial statements 43 | |
| General section 44 | |
| Part A – General basis of preparation 45 | |
| Scope of consolidation 45 | |
| Consolidation method 46 | |
| Share-based payments 46 | |
| Earnings per share 46 | |
| Foreign-currency transactions 46 |
| New accounting standards in force 47 | |
|---|---|
| New accounting standards that have not yet entered into force 47 | |
| Part B – General basis of valuation 55 | |
| Statement of financial position - assets 55 | |
| Tangible assets 55 | |
| Reinsurers' share of technical provisions 56 | |
| Investments 56 | |
| Miscellaneous receivables 59 | |
| Other assets 59 | |
| Cash and cash equivalents60 | |
| Statement of financial position - liabilities 61 | |
| Shareholders' equity attributable to the Group 61 | |
| Shareholders' equity attributable to non-controlling interests 62 | |
| Provisions 62 | |
| Technical provisions 62 | |
| Financial liabilities 62 | |
| Payables 63 | |
| Other liabilities 63 | |
| Other information 63 | |
| Income statement 65 | |
| Net premiums 65 | |
| Commission income 65 | |
| Income and expenses deriving from financial instruments measured at fair value through profit or loss65 | |
| Income deriving from equity investments in subsidiaries, associates and joint ventures 65 | |
| Income deriving from other financial instruments and investment property 65 | |
| Other revenues 65 | |
| Net claims-related expenses 66 | |
| Commission expenses 66 | |
| Expenses deriving from equity investments in subsidiaries, associates and joint ventures 66 | |
| Expenses deriving from other financial investments and investment property 66 | |
| Operating expenses 66 | |
| Other costs 67 | |
| Taxes 67 | |
| Statement of comprehensive income 67 | |
| Statement of changes in shareholders' equity 67 | |
| Statement of cash flows 67 | |
| Use of estimates 67 | |
| Part C – Information on the statement of financial position 69 | |
| Assets 69 | |
| Intangible assets 69 | |
| Tangible assets 70 | |
| Reinsurers' share of technical provisions 71 | |
| Investments 71 | |
| Miscellaneous receivables 74 | |
| Other assets 74 | |
| Cash and cash equivalents75 | |
| Liabilities 75 | |
| Shareholders' equity 75 | |
| Earnings per share 76 | |
| Dividends 77 | |
| Provisions 77 | |
| Technical provisions 77 Financial liabilities 79 |
|
| Payables 80 | |

| Other liabilities 80 | |
|---|---|
| Part D – Information on the income statement 82 | |
| Revenues 82 | |
| Net premiums 82 | |
| Income and expenses deriving from financial instruments measured at fair value through profit or loss83 | |
| Income deriving from equity investments in subsidiaries, associates and joint ventures 83 | |
| Income deriving from other financial instruments and investment property 83 | |
| Other revenues 83 | |
| Costs 84 | |
| Net claims-related expenses 84 | |
| Expenses deriving from other financial instruments and investment property 85 | |
| Operating expenses 85 | |
| Other costs 86 | |
| Taxes 86 | |
| Fair value measurement 89 | |
| Part F – Other information 90 | |
| Revenue or cost elements of exceptional size or impact 90 | |
| Long-term incentives – LTI Plan 90 | |
| Contingent liabilities, purchase commitments, guarantees, pledged assets and collateral 90 | |
| Leases 90 | |
| Information relating to employees, directors and statutory auditors 91 | |
| Fees for auditing and services other than auditing 91 | |
| Schedules attached to the notes to the financial statements 94 | |
| Certification of the consolidated financial statements pursuant to Article 81-ter of Consob | |
| Regulation 11971/1999 193 113 |

Chairman Antonia Boccadoro
Chief Executive Officer Alberto Minali
Ezio Bassi Elena Biffi Claudio Giraldi Elena Pistone Ignazio Maria Rocco di Torrepadula
Chairman Alfredo Michele Malguzzi
Statutory Auditors Rosella Colleoni Alessandro Copparoni
Alternate Auditors Francesco Rossetti Paola Mazzucchelli
GENERAL MANAGER Alberto Minali
******
EXTERNAL AUDITOR KPMG S.p.A.1
1 For external auditors' report, please refer to the Italian's document that has been audited (downloaded on www.revoinsurance.com ).
These financial statements have been prepared pursuant to ISVAP Regulation No. 7 of 13 July 2007 and have been prepared in accordance with applicable legal provisions, according to the valuation criteria and international accounting standards referred to below, and corresponding to the accounting records that reflect the transactions carried out by the Revo Insurance Group (hereinafter also the "Group") at 31 December 2022, supplemented by internal management data not directly identifiable in the accounts.
The Group consists of the parent company, Revo Insurance S.p.A. (hereinafter also the "Parent Company", the "Controlling Company" or "the Company"), and the subsidiary, Revo Underwriting s.r.l. (hereinafter also the "Subsidiary").
The financial statements consist of the:
In accordance with industry regulations, the Italian Civil Code and Consob regulations, the following file is also supplemented with the following documents:
The official document containing the 2022 consolidated financial statements, accompanied by the relevant report on operations, prepared in accordance with the technical requirements established in Commission Delegated Regulation (EU) 2019/815 (European Single Electronic Reporting Format - ESEF), is available, in accordance with the law, on the Company's website (www.revoinsurance.com).
The Revo Insurance Group, entered in the register of insurance groups under No. 059, consists of a Parent Company, REVO Insurance S.p.A., an insurance company created through the reverse merger between Elba Assicurazioni S.p.A. and the parent company, Revo S.p.A., and an insurance brokerage company, Revo Underwriting s.r.l., operational since July 2022.
Revo Insurance S.p.A. is an insurance company operating in the non-life business with its registered office at Viale dell'Agricoltura 7, Verona.
Revo Underwriting, an insurance brokerage and advisory services company, operates as an MGA (managing general agency), i.e. an agency authorised to write, issue and manage insurance policies, under licences and authorisations held by the insurance company, as well as own its risk capital. The Subsidiary, with its registered office at Via Dei Bossi 2/A, Milan, has been acting as an agency since 6 July 2022 (date of entry in the register).
At 31 December 2022, the Parent Company held own shares (a total of 140,953 shares), amounting to 0.573% of the share capital, consisting solely of ordinary shares, and is listed on the Euronext STAR Milan market and therefore subject to the rules of the Euronext Milan Issuers' Regulation.
There are no associates, companies under joint control or other related parties.

The Group is overseen by IVASS, the Italian insurance supervisory authority, which has its registered office at Via del Quirinale 21, Rome.
The consolidated financial statements have been audited by the External Auditor, KPMG S.p.A., charged with auditing the accounts for the 2017-2025 financial years.
In this file, the financial statements relating to the Group's financial position and earnings, composed as described above, at 31 December 2022 are compared with data relating to the consolidated financial statements for the year ended 31 December 2021, for Revo S.p.A. and Elba Assicurazioni S.p.A.
The legal, organisational and management structure of the Revo Insurance Group is linear, with the Parent Company holding 100% of the share capital of Revo Underwriting S.r.l., an insurance brokerage firm, active since 6 July 2022, which is responsible for insurance advisory services.
Pursuant to IVASS Regulation No. 30, the main intercompany entries recorded during the period are shown below, regardless of their materiality.
The Revo Insurance Group operates exclusively in the non-life business in the insurance market.
Insurance business is carried out by the Parent Company, Revo Insurance S.p.A.
As at 31 December 2022, the Revo Insurance Group operates in Italy and abroad under the freedom to provide services scheme2, in the following areas of activity3, as defined in Article 2, paragraph 3 of the Italian Private Insurance Code (Decree-Law No. 209 of 7 September 2005): 1. Accident, 2. Sickness, 3. Land vehicles (other than railway rolling stock), 4. Railway rolling stock, 5. Aviation hull, 6. Marine hull (sea, lake and river and canal vessels), 7. Goods in transit, 8. Fire and natural forces, 9. Other damage to property, 11. Aviation liability, 12. Marine hull (sea, lake and river and canal vessels), 13. General liability, 14. Credit, 15. Suretyship, 16. Miscellaneous financial loss and 18. Assistance.
2 It should be noted that since 4 July 2022 the Parent Company has been authorised to operate under the freedom to provide services scheme.
3 It should be noted that authorisation for the Sickness, Land vehicles, Railway rolling stock, Aviation hull, Marine hull, Goods in transit, Aviation liability, Marine liability, Credit and Financial loss classes was obtained from the Supervisory Body on 29 March 2022 and that, on the same date, the Company was authorised to extend its reinsurance activities to the Accident, Fire and natural forces, Other damage to property and General liability classes.

9 TABLE OF CONTENTS
2022 was marked by dramatic geopolitical events and the continuation of the Covid-19 pandemic in various areas of the globe. In a still fragile macroeconomic environment, the outbreak of war between Russia and Ukraine amplified the rise in commodity prices.
This trend, together with the effects of the fiscal expansion of 2020-2021, changed the paradigms of the financial market, particularly in relation to bond yields, with effects that are likely to persist for the next few years.
February saw the military invasion of Russian troops into Ukrainian territory. As well as its dramatic humanitarian consequences, the conflict had a particularly negative impact on trade flows and commodity prices, at a time when some of the global production chain "bottlenecks" caused by the pandemic seemed to be coming to an end. Further uncertainty was caused by the Chinese government's restriction on industrial and commercial activities in large areas of the country, in an effort to curb another surge in Covid-19 cases.
Central banks have been faced with the difficulty of managing an economic scenario characterised by a rapid deterioration in current and forward-looking indicators and a particularly sharp and persistent rise in inflation. While the main activity of central bankers was controlling inflation in the second quarter, prompting expectations of a sharp rise in policy rates, towards the end of June the focus shifted to the risks of recession, due to overly restrictive financial conditions and potential energy rationing. The findings of early autumn price surveys shifted the focus to the risk of inflation being well beyond the central banks' targets and to the threats to financial stability posed by the tightening of monetary policy within a particularly short time frame.
In a generally fragile environment, the European Central Bank acted initially with caution, partly in view of the fact that European inflation was being driven more by rising commodity and energy prices than by demand. From July onwards it implemented a number of hikes, bringing the deposit rate to 2% by year-end, with, in conclusion, further increases expected during 2023 as the bond purchase programmes are phased out.
In the period under review, the Federal Reserve progressively increased its key rate from March (eventually reaching 425 basis points overall at year-end), and began reducing the number of bonds held on its balance sheet in an effort to contain the monetary base and its impact on price dynamics.
The growth recorded in 2022 in the main areas of the planet was still remarkably positive, driven by the impetus of postpandemic re-openings and incorporating only partially the impacts of the geopolitical picture described above.
The recessionary effects of the sudden normalisation of rates and the rise in commodity prices affected GDP in the second half of the year and the overall result for 2022. Specifically, Italy recorded growth of 0.2% in the first quarter compared with the previous quarter and 6.4% compared with the same period in 2021. In the second quarter, GDP continued to grow by 1.1% compared with the first quarter and by 5.0% compared with the previous year, while in the third and fourth quarters there were clear signs of a slowdown, with growth of 0.5% compared with the June figure and 2.7% compared with the same period in 2021. Overall, growth is estimated at 3.8% for 2022, while forecasts for subsequent years point to much lower GDP figures.
Inflation, which had been rising since mid-2021, accelerated strongly during the first half of the year, reaching record levels in both Europe and the United States. Energy and food were the main contributors, but core inflation also rose as the range of goods and services affected by higher prices continued to grow. This upward trend can also be seen in Italian inflation, which rose from +6.0% in the first quarter to +12.5% at the end of the year.

In a macroeconomic environment dominated by the war between Russia and Ukraine, higher commodity prices and double-digit inflation rates, ISTAT estimates have confirmed a positive performance by the Italian economy, with an increase in GDP of 2.7% in the third quarter, compared with the same period in 2021. GDP growth was given a substantial boost by the services sector, while the agricultural and industrial sectors contracted. In the services sector, life and nonlife insurers recorded differing performance trends. In particular, new life production declined to its lowest level in eight years, while the non-life segment registered a general increase in premiums.
According to industry studies4, in the non-life sector, at the end of the third quarter of 2022, total premiums collected by insurance companies and Italian representative offices in the Italian direct portfolio amounted to €29.0 billion, up by 6.3% compared with the end of the same period in 2021, when premiums written totalled €27.2 billion and the sector recorded growth of 2.8%, driven by the post-pandemic recovery. The third quarter of 2022 produced the seventh consecutive positive interim increase, with premium income reaching €30 billion for the first time at the end of the first nine months of the year.
The increase in total non-life premiums was due in particular to growth in the non-motor sector, the Company's core market, which recorded its highest ever increase (+11.6%), compared with a slight decrease (-0.5%) in premiums in the motor sector.
The other classes were positively affected by the recovery in domestic production. All the main insurance classes contributed to the overall growth of the segment (11.6%): the Accident and Sickness classes grew by 5.4% and 14.5% respectively, the Fire class by 7.1% and Other damage to property by 10.6%, while General liability grew by 12.1%.
The non-life business also recorded growth in the Credit (+30%) and Suretyship (+9.6%) classes. The National Recovery and Resilience Plan (NRRP)'s boost to the procurement sector has also helped to increase insurance premiums in the Suretyship sector, while the growth in Credit premiums was boosted by insurance companies being able to access a €2 billion fund, set up in 2020, which enabled insurers to continue providing cover to businesses experiencing cash flow crises due to the pandemic.
Moreover, in the future, a large majority of operators estimate that requests for insurance cover may increase in the SME segment, driven mainly by increased demand from the services sector, followed by manufacturing.
According to the study "Next Level for Insurance – SME segment" by Crif, the IIA (Italian Insurtech Association) and Nomisma, only 62% of Italian SMEs currently have insurance cover. The entire segment of Italian small and medium-sized enterprises, which is the REVO Group's core market, comprising 4.35 million companies and representing 99.3% of active businesses, with a strategically important role in the socio-economic fabric of the country, is heavily under-insured: 1,653,000 of these enterprises (or 38% of the total, based on the sample analysed) have no insurance cover. SMEs have a low perception of the risks involved in business and therefore tend to underestimate the impact an event might have on their activities. In fact, as well as being an under-insured segment, there is a widespread tendency to purchase as little as possible: 71% of SMEs have taken out third-party liability cover, 64% have fire cover and 56% theft cover, and only 39% have directors' liability cover. To address this scenario, the response of insurance companies for the next 12 months will be to increase insurance advice, which will become increasingly strategic, to help businesses develop with a greater focus on risk.
With regard to the distribution channel, the main form of brokerage in terms of market share (73%) is still the agency network, which is particularly successful in the Suretyship, General liability, Motor liability, Marine hull and Other damage to property classes. This year, the banking channel topped the brokers' market share (8.7%) for the first time. This percentage reflects the entire volume of premiums that these intermediaries collect but hand over to companies via agencies. If the market share of these premiums were also taken into account, the percentage of agencies would fall to 49.9% and the percentage of the brokers themselves would rise to 31.8%.
According to the S&P Global Ratings Report ("Global Insurance Markets: Inflation Bites"), also in 2023, although inflation and competition in some segments (particularly motor liability and healthcare) are putting the profits of the world-wide insurance industry at risk, it will remain one of the highest-rated sectors at the global level. The decrease in purchasing
4 Monthly report issued by the industry association, ANIA

power due to the increase in the cost of living may slow growth in premiums, while growth in premiums in the non-life segment will be positively affected by the many mandatory types of cover and by the adjustment of premiums for the new levels of inflation.
Some of the new legislation affecting the insurance sector in 2022 is described below:
2022 saw the creation of the REVO Insurance Group, and was marked by a number of significant corporate events. The most significant events during the year were as follows:

Railway rolling stock, 5. Aviation hull, 6. Marine hull (sea, lake and river and canal vessels), 7. Goods in transit, 11. Aviation liability, 12. Marine liability (sea, lake and river and canal vessels) (carrier's liability only), 14. Credit and 16. Financial loss, as well as the extension of reinsurance to classes 1. Accident, 8. Fire and natural forces, 9. Other damage to property and 13. General liability, pursuant to Article 2, paragraph 3, of the Insurance Code;

Communication No. 0494770, the publication of the securities information document and key facts document (jointly referred to as the "Prospectus") for the admission to trading of the Issuer's ordinary shares and allotment rights on Euronext STAR Milan. Pursuant to the provisions of the deed of merger, when the listing was authorised, the merger simultaneously became effective and on 21 November 2022, it also resulted in a change in the name of Elba Assicurazioni to REVO Insurance S.p.A. and the relocation of the registered office to Verona;
At the Group level, operating performance in the 2022 financial year was characterised by the launch and implementation by the Parent Company of its own strategic plan, presented to the financial community on 31 March 2022, which provided for the further development of the existing insurance business and the broadening of the offer, with the launch of new lines focused on specialty and parametric risks.
The consolidated financial statements for the year ended 31 December 2022 show a pre-tax profit of €5,213,000. After taxes of €103,000, consolidated profit amounted to €5,316,000.
This result was determined by the IAS profit, net of the taxes recorded by Revo Insurance S.p.A., amounting to €5,338,000, partially offset by the IAS losses of Revo Underwriting, amounting to €22,000.
The Group's income statement is set out below, including the contribution of each individual company within the scope of consolidation.
| Income statement | REVO Insurance | REVO Underwriting | Total | |
|---|---|---|---|---|
| 1.1 | Net premiums | 56,704 | - | 56,704 |
| 1.1.1 | Gross premiums earned | 98,517 | - | 98,517 |
| 1.1.2 | Premiums ceded to reinsurance during the year | -41,812 | - | -41,812 |
| 1.2 | Commission income | - | - | - |
| Income and expenses deriving from financial instruments | ||||
| 1.3 | measured at FV through profit or loss | -172 | - | -172 |
| 1.3bis | Reclassification according to the overlay approach (*) | - | - | - |
| Income deriving from equity investments in subsidiaries, | ||||
| 1.4 | associates and joint ventures | - | - | - |
| Income deriving from other financial instruments and | ||||
| 1.5 | investment property | 3,720 | - | 3,720 |
| 1.5.1 | Interest income | 3,416 | - | 3,416 |

| 1.5.2 | Other income | - | - | - |
|---|---|---|---|---|
| 1.5.3 | Realised profit | 304 | - | 304 |
| 1.5.4 | Profit on valuation | - | - | - |
| 1.6 | Other revenues | 2,046 | -28 | 2,018 |
| 1 | TOTAL REVENUES AND INCOME | 62,300 | -28 | 62,272 |
| 2.1 | Net claims-related expenses | -14,010 | - | -14,010 |
| 2.1.1 | Amounts paid and change in technical provisions | -20,395 | - | -20,395 |
| 2.1.2 | Reinsurers' share | 6,386 | - | 6,386 |
| 2.2 | Commission expenses | - | - | - |
| Expenses deriving from equity investments in | ||||
| 2.3 | subsidiaries, associates and joint ventures | - | - | - |
| Expenses deriving from other financial instruments and | ||||
| 2.4 | investment property | -1,839 | - | -1,839 |
| 2.4.1 | Interest expense | -1,562 | - | -1,562 |
| 2.4.2 | Other expenses | - | - | - |
| 2.4.3 | Realised losses | -239 | - | -239 |
| 2.4.4 | Losses on valuation | -38 | - | -38 |
| 2.5 | Operating expenses | -33,214 | 1 | -33,213 |
| 2.5.1 | Commissions and other acquisition expenses | -15,180 | 16 | -15,164 |
| 2.5.2 | Investment management expenses | -172 | - | -172 |
| 2.5.3 | Other administrative expenses | -17,862 | -15 | -17,877 |
| 2.6 | Other costs | -7,996 | -2 | -7,998 |
| 2 | TOTAL COSTS AND EXPENSES | -57,058 | -1 | -57,059 |
| PROFIT (LOSS) FOR THE YEAR BEFORE TAX | 5,242 | -29 | 5,213 | |
| 3 | Taxes | 96 | 7 | 103 |
| Profit (Loss) for the year after tax | 5,338 | -22 | 5,316 |
At the end of the year, adjusted operating profit was €13,879,000. This figure has undergone the following adjustments compared with the operating result in that it:
The table below summarises the components of the adjusted operating result as at 31 December 2022:
| Adjusted operating profit | 31.12.2022 |
|---|---|
| Net premiums | 56,704 |
| Claims-related expenses | -14,010 |
| Operating expenses | -33,213 |
| Other technical expenses | -2,128 |
| Other technical income | 866 |
| Technical result | 8,220 |
| Cost of financial debt | 0 |
| Investment income/expenses | 1,854 |
| Listing and other one-off costs | 2,864 |
| Depreciation of tangible assets | 134 |
| Payment to agencies | 29 |
| LTI | 779 |
| Adjusted operating profit | 13,879 |

For the sake of completeness, adjusted net profit as at 31 December 2022 is shown below, including the same adjustments made to the operating profit shown above and adjusted for the VoBA (value of business acquired) amortisation portion recorded during the year:
| Adjusted net profit | 31.12.2022 |
|---|---|
| Net profit | 5,316 |
| Capital gains/losses on disposal | -65 |
| Valuation gains/losses | 209 |
| Listing and other one-off costs | 2,864 |
| Depreciation of tangible assets | 134 |
| LTI | 779 |
| Payment to agencies | 29 |
| VoBA amortisation | 3,909 |
| Tax adjustment | -2,422 |
| Adjusted net profit | 10,753 |
The technical performance of the insurance portfolio during the year was characterised by:
At 31 December 2022, the new management strengthened the claims reserve, setting aside a greater IBNR of €1,190,000 compared with 2021, with €192,000 ceded to reinsurance.
In particular, it should be noted that the claims reserve increased due to ten large claims relating to cover taken out in the years prior to 2022, with a total negative impact of €2,281,000 net of reinsurance. Four large claims (amounting to more than €200,000) relate to policies taken out in 2022, with a net impact of €821,000, the effect of which has been reduced thanks to the activation of the new reinsurance policy.
The technical balance for reinsurance of €9,396,000 (€5,733,000 at 31 December 2021), following the amendment and streamlining of reinsurance agreements, with a slight reduction in the portion ceded in the existing quota share treaty, and the activation of non-proportional cover to better protect the technical result and the soundness of the Company.
The business development project, in 2022, entailed the following major costs:

Acquisition costs, in the commissions and other direct and indirect business acquisition expenses component, amounted to €41,361,000, up by €24,679,000 on 31 December 2022, which is, however, consistent with the strong growth in premiums recorded in the period. Commissions received from reinsurers amounted to €26,197,000 (€18,732,000 at 31 December 2021), thanks to the growth of business volumes and the amendment of existing agreements.
Due to the above performance, the adjusted COR5 (combined operating ratio) gross of reinsurance was 82.6% (solely to show the change more clearly, we have reported the COR of Elba Assicurazioni S.p.A. at 31 December 2021, equal to 62.3%) and amounted to 85.5% net of reinsurance (49.7% for Elba Assicurazioni at 31 December 2021).
The adjusted COR (combined operating ratio)6 was 78.8% gross of reinsurance (61.7% at 31 December 2021) and 78.8% net of reinsurance (47.8% at 31 December 2021).
The effects of the reinsurance policy on the COR are mainly due to the amendment of the treaties, which led to an extension of the business covered by reinsurance and, at the same time, a decrease in the percentage ceded under quota share treaties.
The financial result, a positive €1,710,000 (a positive €930,000 at 31 December 2021), benefited from an increase in financial income, amounting to €1,854,000, a marked improvement on the same period in the previous year (€628,000), due to the implementation of a careful investment policy that aims both to seize the opportunities offered by an environment of higher interest rates and to increase decorrelation from the performance of the financial markets, with a consequent decrease in overall volatility.
To give a better picture of the Group's performance and operating results, the most significant IAS income and balance sheet data from the 2022 consolidated half-year report, broken down by sector, are provided below. It should be noted that the data presented in the "Other" sector at 31 December 2021 refer to REVO SPAC, while the data at 31 December 2022 refer to REVO Underwriting S.r.l.
| Insurance sector | Other | Total | ||||
|---|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |
| Intangible assets | 92,117 | 90,600 | 11 | 21 | 92,128 | 90,621 |
| Tangible assets | 14,448 | 344 | 0 | 1 | 14,448 | 345 |
| Reinsurers' share of technical provisions | 55,737 | 39,895 | 0 | 0 | 55,737 | 39,895 |
| Investments | 188,531 | 122,343 | 0 | 64,451 | 188,531 | 186,794 |
| Miscellaneous receivables | 52,931 | 21,978 | -75 | 3 | 52,856 | 21,981 |
| Other assets | 7,527 | 2,257 | 1 | 171 | 7,528 | 2,428 |
| Cash and cash equivalents | 4,444 | 4,007 | 210 | 8,389 | 4,654 | 12,396 |
| Total assets | 415,882 | 354,460 | ||||
| Shareholders' equity | 216,632 | 218,478 | ||||
| Provisions | 3,175 | 4,701 | 0 | 0 | 3,175 | 4,701 |
| Technical provisions | 140,074 | 97,004 | 0 | 0 | 140,074 | 97,004 |
| Financial liabilities | 16,048 | 2,568 | 0 | 0 | 16,048 | 2,568 |
| Payables | 31,594 | 7,133 | 19 | 18,019 | 31,613 | 25,152 |
| Other liabilities | 8,340 | 6,557 | 0 | 0 | 8,340 | 6,557 |
| Total shareholders' equity and liabilities | 415,882 | 354,460 |
| Insurance sector | Other | Total | |||||
|---|---|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | ||
| Net premiums | 56,704 | 4,500 | - | - | 56,704 | 4,500 | |
| Commission income | - | - | - | - | - | - |
5 Solely for the purposes of presentation and a better understanding of performance in insurance operations, the figures for Elba Assicurazioni S.p.A. as at 31 December 2021 are shown for comparative purposes. 6 It should be noted that calculation of the adjusted COR for 2021 did not take into account the cost deriving from payment of the agency severance
indemnity, totalling €985,000, which was included in "Other acquisition costs". This cost was, in fact, offset by the use of the relevant provision, set aside in previous years and included in the non-technical account under "Other income". The effect on the result for the period was therefore nil.
| Income and expenses deriving from financial instruments measured at fair value through profit or loss |
-172 | 0 | - | -63 | -172 | -63 |
|---|---|---|---|---|---|---|
| Reclassification according to the overlay approach |
- | - | - | - | - | - |
| Income deriving from equity investments in subsidiaries, associates and joint ventures |
- | - | - | - | - | - |
| Income deriving from other financial instruments and investment property |
3,720 | 41 | - | 1 | 3,720 | 42 |
| Other revenues | 2,046 | 2 | -28 | 1 | 2,018 | 3 |
| Total revenues and income | 62,300 | 4,542 | -28 | -61 | 62,272 | 4,481 |
| Net claims-related expenses | -14,010 | -984 | - | -14,010 | -984 | |
| Commission expenses | - | - | - | - | - | - |
| Expenses deriving from equity investments in subsidiaries, associates and joint ventures |
- | - | - | - | - | - |
| Expenses deriving from other financial instruments and investment property |
-1,839 | -249 | - | -17 | -1,839 | -266 |
| Operating expenses | -33,212 | 3,665 | -1 | -17,432 | -33,213 | -13,767 |
| Other costs | -7,998 | -637 | - | -769 | -7,998 | -1,406 |
| Total costs and expenses | -57,058 | 1,795 | -1 | -18,218 | -57,059 | -16,423 |
| Profit (loss) for the year before tax | 5,242 | 6,337 | -29 | -18,279 | 5,213 | -11,942 |
Following the completion of the acquisition of Elba Assicurazioni S.p.A. by REVO S.p.A. on 30 November 2021, the 2021 consolidated data presented in the schedules in these financial statements show only the insurance activity in December 2021, i.e. as of the date of completion of the transaction.
For this reason, solely for the purposes of presentation and a better understanding of the performance of insurance operations on their own, the following table contains a comparison between the technical items recorded by the Group in 2022 and the data for the entire 2021 financial year of Elba Assicurazioni S.p.A., with comments in the following paragraphs.
| Technical data | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Gross premiums written | 131,388 | 77,526 |
| Change in gross premium reserve | -32,871 | -7,203 |
| Premiums ceded | -53,823 | -31,590 |
| Change in ceded premium reserve | 12,011 | 2,493 |
| Net premiums | 56,704 | 41,227 |
| Claims paid | 16,170 | 13,845 |
| Claims paid ceded | -6,223 | -6,392 |
| Recoveries | -5,915 | -6,389 |
| Recoveries ceded | 2,936 | 3,171 |
| Change in gross claims reserve | 11,755 | 3,317 |
| Change in ceded claims reserve | -3,906 | -1,258 |
| Change in recoveries reserve | -1,615 | -804 |
| Change in ceded recoveries reserve | 807 | 411 |
| Net claims-related expenses | 14,010 | 5,901 |
| Acquisition commissions | 30,705 | 18,110 |
| Other acquisition expenses | 10,656 | 6,629 |
| Commissions received from reinsurers | -26,197 | -18,732 |
| Other administrative expenses | 17,877 | 6,791 |
| Other direct technical income and expenses | 1,096 | 2,362 |
| Other technical income and expenses ceded | 166 | -564 |
| Net loss ratio | 24.7% | 14.3% |
| Net combined ratio | 85.5% | 49.7% |
|---|---|---|
| Net adjusted combined ratio | 78.8% | 47.8% |
Premiums written, gross of reinsurance and net of current year cancellations, totalled €131,388,000 in 2022, a significant increase compared with the €77,526,000 recorded at 31 December 2021 (an increase of 69.5%). Direct and indirect premium income is reported in the following table by class:
| Gross premiums | 31.12.2022 | % | 31.12.2021 | % | Change | |
|---|---|---|---|---|---|---|
| 1 | Accident | 973 | 0.7% | 265 | 0.3% | 267.3% |
| 2 | Sickness | 15 | 0.0% | - | 0.0% | - |
| 5 | Aviation hull | 261 | 0.2% | - | 0.0% | - |
| 6 | Marine hull (sea, lake and river and canal vessels) | 2,205 | 1.7% | - | 0.0% | - |
| 7 | Goods in transit | 2,008 | 1.5% | - | 0.0% | - |
| 8 | Fire and natural forces | 14,730 | 11.2% | 631 | 0.8% | 2234.4% |
| 9 | Other damage to property | 15,918 | 12.1% | 12,231 | 15.8% | 30.1% |
| 11 | Aviation liability | 99 | 0.1% | - | 0.0% | - |
| 12 | Marine liability (sea, lake and river and canal vessels) | 70 | 0.1% | - | 0.0% | - |
| 13 | General liability | 20,977 | 16.0% | 4,714 | 6.1% | 345.0% |
| 14 | Credit | 289 | 0.2% | - | 0.0% | - |
| 15 | Suretyship | 73,229 | 55.7% | 59,674 | 77.0% | 22.7% |
| 16 | Financial loss | 602 | 0.5% | - | 0.0% | - |
| 18 | Assistance | 10 | 0.0% | 11 | 0.0% | -6.5% |
| Total | 131,388 | 100.0% | 77,526 | 100.0% | 69.5% |
In this regard, it should be noted that during the period there was a significant increase not only in Suretyship (+22.7% compared with 2021), which remained the main business class, but also in other classes historically managed by the Company (Other damage to property, General liability and Fire), mainly due to the impetus provided by the expansion of the product range and the distribution network.
At the end of the year, the insurance portfolio was more diversified, with a 55.7% impact on the total premiums of the Suretyship class (77.0% at 31 December 2021), due to greater exposure to other classes, the proportion of which increased from 23.0% at 31 December 2021 to 44.3% at 31 December 2022.
In addition to the description of premium income for the year, the breakdown of premium income by geographical area is shown below:
| Geographical area | 31.12.2022 | 31.12.2021 | % incr. |
|---|---|---|---|
| North | 91,811 | 40,089 | 129.0% |
| Centre | 25,118 | 16,434 | 52.8% |
| South and Islands | 14,082 | 21,003 | -33.0% |
| Abroad | 377 | - | - |
| Total | 131,388 | 77,526 | 69.5% |
In 2022, the Company continued to implement measures to increase the number of agency mandates and the number of free collaboration agreements with brokers, in order to boost both overall production and the productivity of individual intermediaries.
At 31 December 2022, the sales network consisted of 116 multi-firm agents (100 at 31 December 2021) and 53 brokers (16 at 31 December 2021).
During the 2022 financial year, as part of a process designed to strengthen its commercial structure, the Company embarked on a path of harmonisation of the agency network that entailed the awarding of 18 new agency mandates, 37 new free collaboration agreements with brokers and the withdrawal of 2 agency mandates, the results of which were not in line with expectations.
The distribution of agencies (including brokers) and the average premiums written at 31 December 2022 by geographical area are as follows:

| Geographical area | No. of agencies/brokers by geographical area |
Overall premiums |
Average premiums per Agency/Broker 2022 |
Average premiums per Agency/Broker 2021 |
|---|---|---|---|---|
| North | 76 | 91,811 | 1,208 | 978 |
| Centre | 47 | 25,118 | 534 | 483 |
| South and Islands | 46 | 14,082 | 306 | 512 |
| Total | 169 | 131,011 | 775 | 668 |


Claims-related expenses for direct and indirect business at 31 December 2022 amounted, respectively, to €20,395,000 gross of reinsurance (€9,969,000 at 31 December 2021) and €14,010,000 net of reinsurance (€5,901,000). The following tables show the breakdown by item, both gross and net of reinsurance:
| Gross claims-related expenses | 31.12.2022 | 31.12.2021 | Change | ||
|---|---|---|---|---|---|
| Change in claims reserve | 11,755 | 3,317 | 254% | ||
| Amounts paid | 16,170 | 13,845 | 17% | ||
| Change in recoveries | -7,530 | -7,193 | 5% | ||
| Total | 20,395 | 9,969 | 105% | ||
| Net claims-related expenses | 31.12.2022 | 31.12.2021 | Change |
| Change in claims reserve | 7,849 | 2,059 | 281% |
|---|---|---|---|
| Amounts paid | 9,947 | 7,453 | 33% |
| Change in recoveries | -3,786 | -3,611 | 5% |
| Total | 14,010 | 5,901 | 137% |
The overall performance of net claims-related expenses at 31 December 2022, measured in terms of net loss ratio, was, although it increased, appropriate for the development of production, standing at 24.7%, compared with 14.3% in 2021. In absolute terms, claims-related expenses increased by €8,109,000, mainly due to the effect of Class 9-Other damage to property (€3,506,000) and Class 13-General liability (€2,316,000). For Class 6-Marine hull and Class 7-Goods in transit, which were not present in the previous year, total net expenses of €842,000 were recorded.
The following tables show the breakdown by class, respectively gross and net of reinsurance:
| Gross claims-related expenses | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| 1 Accident |
224 | 25 | 199 |

| Gross claims-related expenses | 20,395 | 9,969 | 10,426 | |
|---|---|---|---|---|
| 15 | Suretyship | 7,795 | 7,057 | 738 |
| 13 | General liability | 4,280 | 1,523 | 2,757 |
| 9 | Other damage to property | 5,127 | 1,151 | 3,976 |
| 8 | Fire and natural forces | 1,568 | 213 | 1,355 |
| 7 | Goods in transit | 511 | - | 511 |
| 6 | Marine hull (sea, lake and river and canal vessels) | 891 | - | 891 |
| Net claims-related expenses | 31.12.2022 | 31.12.2021 | Change | |
|---|---|---|---|---|
| 1 | Accident | 190 | 25 | 165 |
| 6 | Marine hull (sea, lake and river and canal vessels) | 540 | - | 540 |
| 7 | Goods in transit | 302 | - | 302 |
| 8 | Fire and natural forces | 843 | 93 | 750 |
| 9 | Other damage to property | 4,657 | 1,151 | 3,506 |
| 13 | General liability | 3,212 | 896 | 2,316 |
| 15 | Suretyship | 4,266 | 3,736 | 530 |
| Gross claims-related expenses | 14,010 | 5,901 | 8,109 |
The total claims ratio, gross of reinsurance, was 20.7%, compared with 14.2% at 31 December 2021. The claims ratio net of reinsurance was 24.7%, compared with 14.3% for the same period in 2021.
As shown above, the increase in claims-related expenses mainly reflects the increase in the change in the claims reserve of €7,041,000 and, to a lesser extent, higher claims paid of €2,734,000.
The claims reserve was strengthened by setting aside IBNR, net of reinsurance, of €1,448,000, resulting from a physiological trend of increased overall business. Taking into account the most significant claims, with a pay-out of more than €200,000, there was an increase in the claims reserve due to ten claims relating to cover taken out in previous years (two relating to Class 9-Other damage to property for €705,000, three relating to Class 13-General liability for €912,000 and five relating to Class 15-Suretyship for €665,000), with a total negative impact of €2,281,000 net of reinsurance, and four claims relating to policies taken out in 2022 with a net impact of €821,000 (one relating to Class 13-General liability for €314,000, one to Class 8-Fire for €171,000 and two relating to Class 6-Marine hull for €336,000).
The technical performance in 2022, due to the Company's particular focus on customer retention, the constitution of adequate guarantees and risk assessment during the underwriting phase, once again proved extremely profitable.
The ratio, gross of reinsurance, of claims paid and reserved, net of recoveries, to earned premiums, was 12.5% (12.9% at 31 December 2021), and 13.1% net of reinsurance, compared with 13.9% at 31 December 2021.
Net claims for the year increased by €530,000 compared with 31 December 2021, due to the increase in claims paid and reserved (€693,000) versus the positive change in recoveries (€163,000).
A large claim was reported, adequately covered by collateral, which had been provided as usual in order to protect against this type of risk and which led to a reduction in the amount paid out.
In the other non-life insurance classes, the ratio, gross of reinsurance, of claims paid and reserved net of recoveries (including an IBNR provision of €1,640,000, up from €450,000 in 2021) to earned premiums was 35.3% overall (18.6% at 31 December 2021).
Of the IBNR provisioned in the financial statements, €192,000 was ceded to reinsurance. The overall ratio of the other classes, net of reinsurance, was 40.5%, compared with 15.2% in 2021. The increase in this ratio in 2022 was mainly due to the following trends:

Total operating expenses at 31 December 2022 came to €59,408,000 gross of reinsurance and €33,213,000 net of reinsurance, an increase compared with the same period in 2021 and in line with the increase in business volume. A detailed summary is provided below:
| Operating expenses | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Commissions and other acquisition expenses | 15,164 | 6,007 |
| Investment management expenses | 172 | - |
| Other administrative expenses | 17,877 | 6,791 |
| Operating expenses | 33,213 | 12,798 |
| Commissions and other acquisition expenses | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Acquisition commissions | 30,705 | 18,110 |
| Other acquisition expenses | 10,656 | 6,569 |
| Collection commissions | - | 60 |
| (-) Commissions and share of profits received from reinsurers | 26,197 | 18,732 |
| Commissions and other acquisition expenses | 6,007 |
The overall impact of acquisition expenses, including other acquisition expenses relating to payroll costs in the technical and commercial areas (€7,975,000, up by €4,460,000 compared with 2021) and directly attributable general expenses (€1,508,000), was 31.4% of premiums written, down slightly from 31.8% at 31 December 2021. The net impact, taking into account the fees received from reinsurers and premiums ceded, was 19.5%, compared with 13.0% in 2021.
Acquisition commissions as a percentage of gross premiums written were 23.4%, in line with the figures at 31 December 2021 (23.4%). Similarly, other acquisition expenses as a percentage of gross premiums written were 8.1% (8.5% at 31 December 2021).

Fees received from reinsurers as a percentage of premiums ceded were 48.7%, compared with 59.3% in 2021. The decrease mainly reflects the difference in the mix of the ceded portfolio: in 2022 there were more optional cessions as well as the activation of excess of loss and quota share cessions in classes other than Suretyship.
Other administrative expenses as a percentage of gross premiums written, mainly due to the cost of the remaining employees, general expenses not directly attributable and depreciation of tangible assets, amounted to 13.6% (8.8% at 31 December 2021). In this context, the following should be noted:
Overall, at 31 December 2022, total operating expenses as a percentage of gross premiums written were 45.2%, and 42.8% net of reinsurance (in the previous year these percentages were 40.7% and 27.9%, respectively7), most of which arose from the increase in payroll expenses due to the implementation of the development plan and one-off expenses incurred for the listing, the merger and the Company's implementation of the new IFRS 17 accounting standard.
During the year, the Company carried out insurance activities under the freedom to provide services scheme in the territory of the Member States of the European Community, including States in the European Economic Area, following the authorisation received from IVASS on 4 July 2022.
The following table sets out the breakdown of technical items relating to foreign business:
| 31.12.2022 | |
|---|---|
| Premiums | 2,259 |
| Change in premium reserve | 1,002 |
| Operating expenses | 575 |
| Total | 682 |
The Company's reinsurance policy in 2022 was based on entering into contracts designed to optimise its overall risk profile, protecting the Company against unexpected/sudden events such as "large" claims, including catastrophe claims, and increasing its ability to fulfil its obligations to policyholders.
Treaties continued to be signed with leading reinsurance companies, significantly reducing the Group's counterparty risk. The minimum rating of the companies included in the panel was greater than or equal to an A- rating from Standard & Poor's and an A- rating from A.M. Best.
Quota and excess of loss treaties were agreed for Suretyship policies (as in previous years) and quota and excess of loss treaties for other non-life policies, except for Assistance and Fine art policies, for which quota share treaties were signed, and for Engineering LoB policies, for which it was decided to maintain only excess of loss cover.
The following table sets out the breakdown of the technical reinsurance balance compared with the previous year:
7 The percentages were obtained on the basis of the "technical data" table in the "Performance of insurance operations" section.
| Technical reinsurance account | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Premiums ceded | -53,823 | -31,590 | -22,233 |
| Change in ceded premium reserve | 12,011 | 2,493 | 9,518 |
| Reinsurers' share of claims | 6,223 | 6,392 | -169 |
| Reinsurers' share of change in recoveries | -3,744 | -3,582 | -162 |
| Reinsurers' share of change in claims reserve | 3,906 | 1,258 | 2,648 |
| Commissions received from reinsurers | 26,197 | 18,732 | 7,465 |
| Technical income and expenses ceded | -166 | 563 | -729 |
| Total | -9,396 | -5,734 | -3,662 |
Premiums ceded increased as a result of both new production and the new proportional, non-proportional and optional treaties signed in 2022.
Earned premiums ceded to reinsurance increased, mainly due to the new reinsurance policy, which involved the signing of new quota share treaties, as well as a reduction in the percentage ceded in the Suretyship quota share treaty (from 50% in 2021 to 40% in 2022).
Ceded claims for the year also increased by a total of €2,318,000, due to the cession of the classes related to the new quota share treaties and three new claims ceded with excess of loss treaties in the Other damage to property and General liability classes, totalling €602,000.
In 2022, the product range was extended to include property, technological risks, corporate civil liability and accidents. In particular, after obtaining authorisation from IVASS to operate in new regulatory classes, the Company further extended its insurance offering through:
In June REVO Insurance S.p.A. also launched the new proprietary technological platform, OverX, a fundamental tool for the structuring and creation of new insurance products, capable of significantly simplifying underwriting processes (use of a common database) and distribution (flexibility and ease of connection to intermediaries).
OverX is a highly innovative information system concerning of flexibility, level of service, response times, efficiency, and the possibility of customizing products, allowing you to easily create the interface with the operating systems of the main intermediaries, guaranteeing a high level of integration with their systems. During 2022, the new specialty lines and parametric products were progressively implemented within the platform with the aim of simplifying the risk analysis processes (so-called underwriting) through the automated reading of communications with the intermediary, the collection and organization of the information necessary for risk assessment, also by external databases, as well as the preparation of insurance contracts.
OverX was developed and created in the Cloud environment, using the most modern technologies, such as Artificial Intelligence, application programming interface (API), advanced security systems, an innovative process automation system and a text recognition system, with a simple and efficient data structure, which facilitates the collection of information by intermediaries.
In 2022, the Company's investment policy was based on prudent criteria. The guidelines also take into account the framework resolution referred to in Article 8 of IVASS Regulation No. 24/2016, which was updated by the Board of Directors on 24 November 2022. It should be noted that updates to the framework resolution are designed to ensure both greater flexibility in investments in securities and greater diversification of portfolio instruments.
In 2022, in particular, foreign government securities with high credit ratings were purchased, including from Germany, the Netherlands, France and Belgium. In the first half of the year, corporate bonds were purchased, mainly from foreign issuers with high ratings, and one open-ended alternative investment fund was subscribed to a limited extent. In the second half of the year, domestic 5-year government bonds totalling €8,545,000 were acquired, in accordance with statutory accounting principles, taking advantage of particularly favourable market conditions.
The asset portfolio has a particularly low duration of approximately two years and an excellent level of liquidity. All portfolio positions are denominated in euro.
The Company's prudent policy in terms of investments and issuer quality serves to protect it from market risk and liquidity risk, despite the current fragile economic scenario. The increased diversification in terms of asset class and issuers is intended to make the portfolio more resistant to market fluctuations and increased volatility in domestic government bond spreads.
Total investments at 31 December 2022 amounted to €188,531,000 (€189,794,000 at 31 December 2021), including €181,339,000 in bonds and other listed fixed-rate securities (including 54.1% in Italian government securities and 45.9% in foreign government securities and other bonds), in addition to €2,620,000 relating to units in bond funds. Shares and quotas of companies include a €556,000 investment in Mangrovia Blockchain Solutions S.r.l.
This item includes, in assets measured at amortised cost, the escrow account set up following the acquisition of Elba Assicurazioni S.p.A., amounting to €4,016,000 (€8,000,000 at 31 December 2021). The escrow account will be reduced by €1,000,000 annually from 30 November 2023 until the account balance is zero (on 30 December 2026).
At 31 December 2022, cash and cash equivalents amounted to €4,654,000 (€12,396,000 at 31 December 2021). The following table sets out the breakdown of investments compared with the previous year:
| Investments and cash and cash equivalents | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Investment property | - | - |
| Equity investments in subsidiaries, associates and joint ventures | - | 1 |
| Financial assets measured at amortised cost | 4,016 | 8,000 |
| Financial assets measured at fair value through OCI | 181,895 | 141,126 |
| Financial assets measured at fair value through profit or loss | 2,620 | 37,668 |
| Total investments (excluding cash and cash equivalents) | 188,531 | 186,794 |
| Cash and cash equivalents | 4,654 | 12,396 |
| Total (including cash and cash equivalents) | 193,185 | 199,190 |

| Investments by type | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Shares and quotas | 556 | - |
| Foreign corporate bonds | 22,480 | 12,624 |
| Italian corporate bonds | 4,861 | 2,608 |
| Italian government bonds | 97,987 | 120,542 |
| Foreign state/government bonds | 56,011 | 5,352 |
| Mutual fund units | 2,620 | 37,668 |
| Total investments (excluding cash and cash equivalents) | 184,515 | 178,793 |
| Cash at bank and in hand | 4,654 | 12,396 |
| Total investments (including cash and cash equivalents) | 189,169 | 191,189 |

Shares and quotas


At 31 December 2022, the workforce consisted of 151 employees, in addition to 6 external contractors and 1 intern (at 31 December 2021, there were 98 employees, plus 1 external contractor).
The substantial increase compared with 2021 (+53 resources) is mainly due to the recruitment of new staff to develop the Company's new business lines, authorised by IVASS at the end of March 2022, and the launch of the development project, with the simultaneous strengthening of staff structures and key functions.
The internal structure by area of expertise breaks down as follows:
| 31.12.2022 | 31.12.2021 | |
|---|---|---|
| CEO/GM | 1 | 1 |
| Specialty Insurance Solutions | 92 | 59 |
| Operations | 19 | 14 |
| Finance Planning and Control | 11 | 7 |
| Legal & Corporate Affairs | 10 | 7 |
| Parametric Insurance Solutions | 6 | 4 |
| Risk Management | 3 | 1 |
| Human Resources and Organisation | 3 | 2 |
| Compliance | 2 | 1 |
| Staff | 2 | 0 |
| Actuarial | 1 | 1 |
| Internal Audit | 1 | 1 |
| Total | 151 | 98 |
During the year, the training of employees continued in order to promote professional and managerial growth, with a particular focus on new hires.
In April 2022, the Smart Working tool was introduced and adopted through the signing of individual agreements with all company employees.
Last but not least, the Company decided to identify new headquarters in Milan, with collaborative workspaces and a strong sustainability footprint. These new operational headquarters were identified at Via Monterosa 91, Milan (the move is scheduled for April 2023).

Total labour costs, including the reimbursement of expenses (employees and contractors on project-based contracts) in 2022 were €15,746,000 (€6,726,000 in 2021). The substantial change compared with 2021 mainly reflects the increase in total remuneration due to the recruitment of a further 53 resources during 2022.
At the Shareholders' Meeting of 4 April 2022, the Company adopted a remuneration policy in accordance with the provisions of the legislation applicable to listed companies and in compliance with the specific provisions in this regard set out in IVASS Regulation No. 38.
The management remuneration system comprises the following main elements:
In particular, the remuneration system for top management, in addition to the Chief Executive Officer and employees of the Company who perform managerial roles or functions, consists of a fixed and a variable component, the latter with an annual component and a deferred long-term incentive plan, in line with best practice at national and international level.
The annual variable component consists of the "MbO" system, which provides for the payment of a cash bonus, subject to the achievement of predetermined annual objectives - both quantitative (operating result and premium income) and qualitative (on a personalised basis) - that are commensurate with the specific role and activities performed by the individual beneficiary.
On 4 April 2022, the Company's Shareholders' Meeting also approved a performance share plan called the "2022-2024 Performance Share Plan" (hereinafter, the "Plan"), the rules of which were drawn up and approved by the Board of Directors on 26 May 2022.
The Plan is a valid tool for retaining and motivating individuals who play a key role in achieving the Company's objectives, and for aligning the interests of key company resources with those of other stakeholders, with a view to long-term sustainable development.
The value of the LTI item at 31 December 2022 was €779,000.
Employees and contractors are required to scrupulously observe the rules of conduct established in the Code of Ethics adopted by REVO Insurance S.p.A. by resolution of the Board of Directors of 21 March 2022.
This document establishes the specific rules and procedures of conduct which, in line with principles of a commitment to fairness and consistency of approach, must be observed by employees and contractors in their multiple relationships with policyholders, agents, suppliers, service providers and any other company or entity, whether public or private, that comes into contact with the Company.
No cases of non-compliance in this regard were reported or discovered during 2022.
The Subsidiary, Revo Underwriting, which is responsible for insurance brokerage and advisory services and operates as the Group's MGA (managing general agency), has been active since 6 July 2022, the date of entry in the Single Register of Insurance and Reinsurance Intermediaries (RUI) with registration number A000711224.

The company has recognised revenues of €67,000, costs associated with the marketing of insurance products of €51,000, and incorporation costs and costs associated with administrative services of €44,000. The result for the year is therefore a loss after tax of €22,000.
Further to the above, the summary figures are presented below, in thousands of euro, for the year ended 31 December 2022 compared with the previous year. Following the acquisition of Elba Assicurazioni S.p.A. in November 2021, only the insurance income data for December is provided below:
| Assets | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Intangible assets | 92,128 | 90,620 |
| Tangible assets | 14,448 | 344 |
| Investments | 188,531 | 186,794 |
| Reinsurers' share of technical provisions | 55,737 | 39,895 |
| Receivables | 52,856 | 21,982 |
| Other assets | 7,528 | 2,428 |
| Cash and cash equivalents | 4,654 | 12,396 |
| Total assets | 415,882 | 354,460 |
| Shareholders' equity and liabilities | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Shareholders' equity | 216,632 | 218,478 |
| Technical provisions | 140,074 | 97,004 |
| Provisions | 3,175 | 4,701 |
| Financial liabilities | 16,048 | 2,568 |
| Payables | 31,613 | 25,152 |
| Other liabilities | 8,340 | 6,557 |
| Total liabilities and shareholders' equity | 415,882 | 354,460 |
| Income statement | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Net premiums earned | 56,704 | 4,500 |
| Commission income | 0 | 0 |
| Income and expenses deriving from financial instruments measured at FV through profit or loss | -172 | -63 |
| Income deriving from equity investments in subsidiaries, associates and joint ventures | 0 | 0 |
| Income deriving from other financial instruments and investment property | 3,720 | 42 |
| Other revenues | 2,018 | 3 |
| Total revenues and income | 62,272 | 4,481 |
| Net claims-related expenses | -14,010 | -984 |
| Commission expenses | 0 | 0 |
| Expenses deriving from equity investments in subsidiaries, associates and joint ventures | 0 | 0 |
| Expenses deriving from other financial instruments and investment property | -1,839 | -266 |
| Operating expenses | -33,213 | -13,767 |
| Other costs | -7,998 | -1,406 |
| Total costs and expenses | -57,059 | -16,423 |
| Profit (loss) for the year before tax | 5,213 | -11,942 |
| Taxes | 103 | -1,900 |
| Profit (loss) for the year after tax | 5,316 | -13,842 |
Information on the Group's Solvency II solvency margin, calculated on the basis of the information available today, compared with the annual 2021 data, is provided below:
Information on the solvency margin - Solvency II 31.12.2022 31.12.2021
| Solvency Capital Requirement | 52,304 | 51,506 |
|---|---|---|
| Eligible Own Funds to meet the SCR (Tier 1) | 142,550 | 139,775 |
| Solvency Ratio | 272.5% | 271.4% |
| Minimum capital requirement | 14,652 | 12,877 |
| MCR Coverage Ratio | 972.9% | 1085.5% |
The results obtained show the high level of Solvency II coverage available to the Company.
The Solvency II Ratio of 272.5%% at 31 December 2022 benefited from the capital received from REVO S.p.A. following the merger and is in line with the solidity and risk appetite objectives contained in the Business Plan.
It should be noted that the Solvency II Ratio does not take into account the organisational provision of €8 million to cover start-up expenses (set aside in response to the authorisation to operate in the new insurance classes), which has to be excluded from the calculation of own funds for the first three financial years.
The solvency position will be the subject of the relevant disclosure to the market and to the Supervisory Authority within the time limits set by the legislation in force in the context of publication of the Solvency and Financial Condition Report (SFCR).
The Group's risk management is designed to comply with regulatory provisions, including constant monitoring according to the provisions of IVASS Regulation No. 24/20216. The Parent Company has defined and implemented its risk assumption, measurement and management policies, taking an integrated view of its assets and liabilities in accordance with European Solvency II rules.
Since May 2022, the Risk Management function has been entrusted to Linda Tso, who, for the areas within her remit, has played her part in the activities planned for Solvency II reporting.
With regard to liquidity, underwriting and counterparty risks, ordinary monitoring activities continue to be overseen at all times, in order to ensure the Company's ongoing ability to meet its commitments. Furthermore, with reference to the internal solvency objective established in Article 18 of IVASS Regulation No. 38/18, the current assessments have not brought to light any critical issues that require specific action.
The Group, also throughout 2022, was required by the Supervisory Authority to monitor its solvency position on a monthly basis, pursuant to the communication dated 17 March 2020. The results of these monthly assessments demonstrate a high and constant capital solvency level.
The Group underwent an organisational enhancement during the year, following the merger in November 2022. The Risk Management function was strengthened with new resources (internal and outsourced) and a system of risk oversight tools was created that includes the new risk management policies, Risk Appetite Framework (RAF) and Own Risk and Solvency Assessment (ORSA), as well as a more structured and effective Risk Register.
The Risk Officer's report to the Board of Directors does not highlight any critical issues and notes that the control processes implemented emphasise the Company's commitment to timely compliance with the reference provisions and regulations, to safeguard and protect the activity performed.
Based on the risk mapping undertaken, the highest-intensity risk to which the Group is exposed is its underwriting risk. In particular, the following should be noted:
Revo Insurance takes a conservative approach to underwriting risk, prioritising the financial security of its customers, in order to avoid taking on risk that could undermine the Company's solvency or constitute a serious obstacle to the achievement of its objectives.

The main techniques used by the Company to mitigate underwriting risk are:
With regard to the assumption of risks in the Suretyship class, which is the Company's core business, policies are written following careful technical investigations to establish both the nature and characteristics of the risks to be covered and the soundness in terms of capital, income and cash flow, as well as the reliability, of the obligated entities, depending on the activities they carry out, to which the cover applies.
With regard to reinsurance techniques, quota and excess of loss treaties were entered into for both Suretyship policies and policies for other classes, with the exception of Assistance and Fine art policies, for which specific quota share treaties are in place, and Engineering policies, for which excess of loss cover is in place.
REVO Insurance has a portfolio of assets consisting mainly of government and corporate bonds. Liquid assets are managed to ensure that sufficient resources are always available for normal claims payment.
The Company's prudent policy in terms of investments and issuer quality serves to protect it from market risk and liquidity risk, despite the current economic environment.
All investments are denominated in euro and therefore no currency risk exists.
With regard to concentration risk, there is a significant percentage in the Italian Republic, which at 31 December 2022 amounted to 51.8% of the Group's overall portfolio (approximately 62.9% at 31 December 2021).
The Group is exposed to the risk associated with a deterioration in the creditworthiness of the market counterparties with which it operates and has business and insurance relationships. These exposures mainly derive from reinsurance and co-insurance activities, cash deposits and derivatives transactions with banks, as well as activities with insurance brokers and policyholders, in respect of which receivables are typically generated according to recurring insurance product underwriting patterns.
At the same time, in its investment activities, the Group is subject to the creditworthiness and default risk of the relevant issuers. In addition to the Italian government, any default on the part of issuers in which the Company has exposure could have a negative impact on its financial position, cash flows and results of operations, as well as an effect on its Solvency II Ratio.
Liquidity risk is the risk of not being able to meet obligations to policyholders and other creditors due to the difficulty of converting investments into cash without suffering losses; this risk is monitored through specific stress scenarios based on short- and medium-term cash flow planning.
Operational risk is the risk of losses due to inefficiencies in human resources, processes and systems, including those used for distance selling, or to external events, such as fraud or the actions of service providers; this definition includes legal risk but not strategic or reputational risk.
In the procedures currently in force, operational risk is also quantified in the context of the solvency requirement calculated using the standard formula.
In addition to this quantitative support, "residual" risk is measured, at least once a year, on the basis of the probability of occurrence of the negative event and the severity of its impact, the scale of which is determined using a qualitative and quantitative methodological approach that helps management in mapping risks in order to adequately identify the most exposed areas and to prioritise when implementing action/mitigation plans.
These assessments enable the Company to ascertain the consistency of the results with the Risk Appetite Framework (RAF), outlined by the Company in its risk appetite policy.

There are no disputes pending, except for claims-related insurance disputes and disputes relating to recourse or recovery of receivables actions.
With regard to insurance disputes, it should be noted that in 2022, the Company received an update from its legal counsel concerning a payment order for approximately €250,000, relating to a counterfeit suretyship policy. As of 31 December 2022 the dispute is still ongoing, and as a precautionary measure it was decided to set aside a portion of the contested amount.
Eleven claims were instigated during 2022, of which three were admitted, two were settled and six dismissed. At the date of preparation of this Report (31 December 2022), there were no claims at the investigation stage.
Internal Audit reports on the above claims were issued and the relevant assessments were carried out by the Board of Statutory Auditors and the Board of Directors and, according to the procedures in force, were notified to the Supervisory Authority.
Pursuant to Article 2497 et seq. of the Italian Civil Code, REVO Insurance S.p.A. exercises management and coordination activities over REVO Underwriting S.r.l.
At 31 December 2022, we report the following transactions between REVO Underwriting S.r.l. and REVO Insurance S.p.A.:
The Related Party Transactions Procedure (the "RPT Procedure"), approved by the Issuer's Board of Directors on 26 May 2022 after it obtained a favourable opinion from the independent directors in office on that date, is intended to: (i) regulate procedures for identifying related parties, defining procedures and time scales for preparing and updating the list of related parties and identifying the corporate functions competent for this purpose; (ii) establish rules for identifying transactions with related parties before they are entered into; (iii) regulate procedures for the carrying out of related party transactions by the Company, including through subsidiaries pursuant to Article 93 of the TUF or in any case companies subject to management and coordination; and (iv) establish procedures and time scales for the fulfilment of reporting obligations to the corporate bodies and to the market.
The Procedure is published in the "corporate-governance/corporate-documents/related party transactions" section of the REVO Insurance website (www.revoinsurance.com).
During the year, no transactions were carried out with companies subject to joint control and other related parties.

It should be noted that, as at 31 December 2022, no natural person or legal entity holds, directly or indirectly, a number of shares such as to have a controlling interest in REVO Insurance S.p.A. In view of this, the Company is not subject to the management and coordination of any entity or company.
No other significant events occurred during the year, other than those reported in the initial introductory section.
No significant events occurred after year-end.
In terms of business outlook, it should be noted that following the completion of the reverse merger on 21 November 2022 and the simultaneous listing on the Euronext STAR Milan segment of Borsa Italiana, no further changes to the corporate structure are currently planned.
As part of project development, REVO will continue to implement its business plan in accordance with the strategic guidelines outlined, aiming to further develop its existing business and to expand its offering with the consolidation of new business lines focused on specialty and parametric risks.
In this regard, REVO approved, during the Board of Directors' meeting of 25 January 2023, a rolling plan for 2023-2026, which confirms the scale of the projections announced in the 2022-2025 plan.
The current environment of macroeconomic and geopolitical uncertainty has not had a material impact on REVO's production or margins, partly due to the presence in the business of automatic inflation protection mechanisms for specialty lines products, as well as the flexibility afforded to underwriters when policies are written, with the possibility of adapting pricing to changing market conditions. Moreover, in 2023 the Company believes that there will be a gradual easing of inflation which, in the context of a less critical geopolitical situation than in 2022, is expected to continue to have no effects on operations.
From a financial perspective, higher volatility than in the recent past continued in the second half, with average growth in policy rates and bond yields. In view of this, REVO has adopted an investment policy that focuses on greater diversification, significantly reducing the overall level of risk in the managed portfolio, partly thanks to the high level of liquidity available for investments. In the short and medium term, the Company expects to benefit from the higher yields offered by the market by maintaining overall low investment durations and pursuing its policy of diversification and decorrelation from Italy risk.
It should also be noted that on 17 October, REVO applied to IVASS for authorisation to extend both its insurance and reinsurance activities to the Legal expenses class, which, if authorisation is obtained, will enable the further expansion of services offered to small and medium-sized enterprises.
REVO Underwriting's business will be developed further in 2023, with a strong focus on signing new brokerage mandates with specialised small/medium-sized brokers and third-party agencies specialising in the marketing of specialty or parametric solutions.
With regard to the information required by Article 2428, paragraph 3(3) and (4) of the Italian Civil Code, it should be noted that the Company:

The programme to purchase own shares implemented during the 2022 financial year, totalling €1,247,111 including fees, was launched pursuant to the resolution adopted by the Ordinary Shareholders' Meeting of 3 May 2021, with the aim of having REVO shares available for any external growth transactions effected through an exchange of shares and for incentive plans reserved for the corporate population.
Pursuant to the regulatory provisions on the transparency of relations with public authorities introduced by Law No. 124/2017, it should be noted that in 2022 REVO Insurance S.p.A. received payments of €48,000 relating to employee training costs. The companies have not received any further subsidies, contributions or economic benefits of any kind from public authorities or from other entities indicated in Article 1, paragraph 125 of the said law, with the exception of the above.
For the purposes of full disclosure, although these contributions are excluded from the transparency obligations established in the aforementioned legislation, it should be noted that the National Register of State Aid, publicly available in the section on transparency on the relevant website, publishes the aid measures and the relevant individual aid granted and recorded in the system by the granting authorities for the direct or indirect benefit of each of the Group companies.
The information prescribed by Article 123-bis of Legislative Decree No. 58 of 24 February 1998 as amended is contained in the Report on Corporate Governance and Ownership Structure, approved by the Board of Directors and published jointly with the Report on Operations. The Report on Corporate Governance and Ownership Structure is available on the Company's website (www.revoinsurance.com), in the "Corporate Governance/Corporate Documents" section.
Milan, 9th March 2023 REVO Insurance S.p.A. Chief Executive Officer (Alberto Minali)


35 TABLE OF CONTENTS | Notes to the financial statements
| 31.12.2022 | 31.12.2021 | ||
|---|---|---|---|
| 1 | INTANGIBLE ASSETS | 92,127,738 | 90,620,392 |
| 1.1 | Goodwill | 74,322,710 | 74,322,710 |
| 1.2 | Other intangible assets | 17,805,028 | 16,297,682 |
| 2 | TANGIBLE ASSETS | 14,448,189 | 344,377 |
| 2.1 | Property | 13,972,722 | 0 |
| 2.2 | Other tangible assets | 475,467 | 344,377 |
| 3 | REINSURERS' SHARE OF TECHNICAL PROVISIONS | 55,736,807 | 39,894,995 |
| 4 | INVESTMENTS | 188,530,889 | 186,794,397 |
| 4.1 | Investment property | 0 | 0 |
| 4.2 | Equity investments in subsidiaries, associates and joint ventures | 0 | 1,000 |
| 4.3 | Financial assets measured at amortised cost | 4,016,029 | 8,000,016 |
| 4.4 | Financial assets measured at fair value through OCI | 181,895,099 | 141,125,746 |
| 4.5 | Financial assets measured at fair value through profit or loss | 2,619,761 | 37,667,635 |
| 4.5.1 | Financial assets held for trading | 0 | 0 |
| 4.5.2 | Financial assets designated at fair value | 0 | 0 |
| 4.5.3 | Other financial assets compulsorily measured at fair value | 2,619,761 | 37,667,635 |
| 5 | MISCELLANEOUS RECEIVABLES | 52,855,574 | 21,981,547 |
| 5.1 | Receivables deriving from direct insurance operations | 40,303,271 | 12,826,743 |
| 5.2 | Receivables deriving from reinsurance operations | 968,807 | 86,962 |
| 5.3 | Other receivables | 11,583,496 | 9,067,842 |
| 6 | OTHER ASSETS | 7,528,106 | 2,428,175 |
| 6.1 | Non-current assets or disposal groups available for sale | 0 | 0 |
| 6.2 | Deferred acquisition costs | 0 | 0 |
| 6.3 | Deferred tax assets | 0 | 0 |
| 6.4 | Current tax assets | 5,394,064 | 0 |
| 6.5 | Other assets | 2,134,042 | 2,428,175 |
| 7 | CASH AND CASH EQUIVALENTS | 4,654,474 | 12,395,846 |
| TOTAL ASSETS | 415,881,777 | 354,459,729 |
| 31.12.2022 | 31.12.2021 | ||
|---|---|---|---|
| 1 | NET LIABILITIES | 216,631,562 | 218,477,836 |
| 1.1 | attributable to the Group | 216,631,562 | 218,477,836 |
| 1.1.1 | Capital | 6,680,000 | 23,055,000 |
| 1.1.2 | Other equity instruments | 0 | 0 |
| 1.1.3 | Capital reserves | 170,000 | 207,045,000 |
| 1.1.4 | Earnings reserves and other equity reserves | 215,869,668 | 6,461,758 |
| 1.1.5 | (Own shares) | -1,247,111 | 0 |
| 1.1.6 | Reserve for net foreign exchange gains/losses | 0 | 0 |
| 1.1.7 | Gains or losses on financial assets measured at fair value through OCI | ||
| -6,687,253 | -67,101 | ||
| 1.1.8 | Other gains or losses recognised directly in equity | -3,469,885 | -4,174,732 |
| 1.1.9 | Profit (loss) for the year attributable to the Group | 5,316,143 | -13,842,089 |
| 1.2 | attributable to non-controlling interests | 0 | 0 |
| 1.2.1 | Capital and reserves - non-controlling interests | 0 | 0 |
| 1.2.2 | Gains or losses recognised directly in equity | 0 | 0 |
| 1.2.3 | Profit (loss) for the year attributable to non-controlling interests | 0 | 0 |
| 2 | PROVISIONS | 3,175,588 | 4,700,710 |
| 3 | TECHNICAL PROVISIONS | 140,073,526 | 97,004,143 |
| 4 | FINANCIAL LIABILITIES | 16,047,787 | 2,567,991 |
| 4.1 | Financial liabilities measured at fair value through profit or loss | 0 | 0 |
| 4.1.1 | Financial liabilities held for trading | 0 | 0 |
| 4.1.2 | Financial liabilities designated at fair value | 0 | 0 |
| 4.2 | Financial liabilities measured at amortised cost | 16,047,787 | 2,567,991 |
| 5 | PAYABLES | 31,613,420 | 25,152,189 |
| 5.1 | Payables deriving from direct insurance operations | 0 | 0 |
| 5.2 | Payables deriving from reinsurance operations | 9,060,885 | 790,660 |
| 5.3 | Other payables | 22,552,535 | 24,361,529 |
| 6 | OTHER LIABILITIES | 8,339,894 | 6,556,860 |
| 6.1 | Liabilities of disposal groups held for sale | 0 | 0 |
| 6.2 | Deferred tax liabilities | 336,059 | 3,931,035 |
| 6.3 | Current tax liabilities | 0 | 887,985 |
| 6.4 | Other liabilities | 8,003,835 | 1,737,840 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 415,881,777 | 354,459,729 |

| 31.12.2022 | 31.12.2021 | ||
|---|---|---|---|
| 1.1 | Net premiums | 56,704,347 | 4,499,682 |
| 1.1.1 | Gross premiums earned | 98,516,646 | 7,102,713 |
| 1.1.2 | Premiums ceded to reinsurance during the year | -41,812,299 | -2,603,031 |
| 1.2 | Commission income | 0 | 0 |
| Income and expenses deriving from financial instruments measured at fair value | |||
| 1.3 | through profit or loss | ||
| -171,676 | -62,827 | ||
| 1.4 | Income deriving from equity investments in subsidiaries, associates and joint ventures | 0 | 0 |
| 1.5 | Income deriving from other financial instruments and investment property | 3,720,495 | 41,510 |
| 1.5.1 | Interest income | 3,416,411 | 41,510 |
| 1.5.2 | Other income | 0 | 0 |
| 1.5.3 | Realised profit | 304,084 | 0 |
| 1.5.4 | Profit on valuation | 0 | 0 |
| 1.6 | Other revenues | 2,018,410 | 2,980 |
| 1 | TOTAL REVENUES AND INCOME | 62,271,576 | 4,481,345 |
| 2.1 | Net claims-related expenses | -14,009,631 | -983,805 |
| 2.1.1 | Amounts paid and change in technical provisions | -20,395,208 | -1,314,885 |
| 2.1.2 | Reinsurers' share | 6,385,577 | 331,080 |
| 2.2 | Commission expenses | 0 | 0 |
| Expenses deriving from equity investments in subsidiaries, associates and joint | |||
| 2.3 | ventures | 0 | 0 |
| 2.4 | Expenses deriving from other financial instruments and investment property | -1,838,640 | -266,384 |
| 2.4.1 | Interest expense | -1,561,829 | -152,300 |
| 2.4.2 | Other expenses | 0 | 0 |
| 2.4.3 | Realised losses | -239,150 | -1,919 |
| 2.4.4 | Valuation losses | -37,661 | -112,165 |
| 2.5 | Operating expenses | -33,212,769 | -13,767,303 |
| 2.5.1 | Commissions and other acquisition expenses | -15,164,003 | -1,116,032 |
| 2.5.2 | Investment management expenses | -171,687 | 0 |
| 2.5.3 | Other administrative expenses | -17,877,079 | -12,651,271 |
| 2.6 | Other costs | -7,997,819 | -1,405,981 |
| 2 | TOTAL COSTS AND EXPENSES | -57,058,859 | -16,423,473 |
| PROFIT (LOSS) FOR THE YEAR BEFORE TAX | 5,212,717 | -11,942,128 | |
| 3 | Taxes | 103,426 | -1,899,961 |
| PROFIT (LOSS) FOR THE YEAR AFTER TAX | 5,316,143 | -13,842,089 | |
| 4 | PROFIT (LOSS) ON DISCONTINUED OPERATIONS | 0 | 0 |
| CONSOLIDATED PROFIT (LOSS) | 5,316,143 | -13,842,089 | |
| of which attributable to the Group | 5,316,143 | -13,842,089 | |
| of which attributable to non-controlling interests | 0 | 0 |
| 31.12.2022 | 31.12.2021 | |
|---|---|---|
| CONSOLIDATED PROFIT (LOSS) | 5,316,143 | -13,842,089 |
| Other income after tax without reclassification to the income statement | -3,469,885 | -4,174,732 |
| Change in shareholders' equity of investee companies | ||
| Change in revaluation reserve for intangible assets | ||
| Change in revaluation reserve for tangible assets | ||
| Income and expenses relating to non-current assets or disposal groups held for sale | ||
| Actuarial gains and losses and adjustments relating to defined benefit plans | 690,131 | -14,716 |
| Gains or losses on equity securities designated at fair value | ||
| through OCI | ||
| Change in own creditworthiness on financial liabilities designated at fair value | ||
| Other elements | -4,160,016 | -4,160,016 |
| Other income after tax with reclassification to the income statement | -6,687,253 | -67,101 |
| Change in reserve for net foreign exchange gains/losses | ||
| Gains or losses on financial assets (other than equity securities) measured at fair value through OCI | -6,687,253 | -67,101 |
| Gains or losses on cash flow hedging instruments | ||
| Gains or losses on instruments hedging a net investment | ||
| in a foreign operation | ||
| Change in shareholders' equity of investee companies | ||
| Income and expenses relating to non-current assets or disposal groups held for sale | ||
| Other elements | ||
| TOTAL OTHER COMPREHENSIVE INCOME | -10,157,138 | -4,241,833 |
| TOTAL CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | -4,840,995 | -18,083,922 |
| of which attributable to the Group | -4,840,995 | -18,083,922 |
| of which attributable to non-controlling interests |
| Balance as at 31.12.2020 |
Change in closing balances |
Charges | Adjustments due to reclassification to the income statement |
Transfers | Changes in participating interests |
Balance as at 31.12.2021 |
||
|---|---|---|---|---|---|---|---|---|
| Total attributable to the Group |
Capital | 23,055,000 | 23,055,000 | |||||
| Other equity instruments | 0 | 0 | ||||||
| Capital reserves | 207,045,000 | 207,045,000 | ||||||
| Earnings reserves and other equity reserves | 6,461,758 | 6,461,758 | ||||||
| (Own shares) | 0 | 0 | ||||||
| Profit (loss) for the year | -13,842,089 | -13,842,089 | ||||||
| Other comprehensive income | -4,241,833 | -4,241,833 | ||||||
| Total attributable to the Group | 218,477,836 | 0 | 0 | 0 | 218,477,836 | |||
| Shareholders' | Capital and reserves - non-controlling interests |
0 | 0 | |||||
| equity | Profit (loss) for the year | 0 | 0 | |||||
| attributable | Other comprehensive income | 0 | 0 | |||||
| to non | ||||||||
| controlling | ||||||||
| interests | Total attributable to non-controlling interests | 0 | 0 | 0 | 0 | 0 | ||
| Total | 218,477,836 | 0 | 0 | 0 | 218,477,836 |
| Balance as at 31.12.2021 |
Change in closing balances |
Charges | Adjustments due to reclassification to the income statement |
Transfers | Changes in participating interests |
Balance as at 31.12.2022 |
||
|---|---|---|---|---|---|---|---|---|
| Capital | 23,055,000 | -16,375,000 | 6,680,000 | |||||
| Other equity instruments | 0 | 0 | ||||||
| Capital reserves | 207,045,000 | -206,875,000 | 170,000 | |||||
| Total | Earnings reserves and other equity reserves | 6,461,758 | -13,842,090 | 223,250,000 | 215,869,668 | |||
| attributable to the Group |
(Own shares) | 0 | -1,247,111 | -1,247,111 | ||||
| Profit (loss) for the year | -13,842,089 | 19,158,232 | 5,316,143 | |||||
| Other comprehensive income | -4,241,833 | -5,909,267 | -6,038 | -10,157,138 | ||||
| Total attributable to the Group | 218,477,836 | -1,840,236 | -6,038 | 0 | 0 | 216,631,562 | ||
| Shareholders' | Capital and reserves - non-controlling interests |
0 | 0 | |||||
| equity | Profit (loss) for the year | 0 | 0 | |||||
| attributable | Other comprehensive income | 0 | 0 | |||||
| to non | ||||||||
| controlling | ||||||||
| interests | Total attributable to non-controlling interests | 0 | 0 | |||||
| Total | 218,477,836 | -1,840,236 | -6,038 | 0 | 0 | 216,631,562 |

| 31.12.2022 | 31.12.2021 | |
|---|---|---|
| Profit (loss) for the year before tax | 5,212,717 | -11,942,128 |
| Change in non-monetary items | 23,666,034 | 8,385,177 |
| Change in non-life premium reserve | 20,186,500 | 1,114,726 |
| Change in claims reserve and other non-life technical reserves | 7,041,071 | 204,484 |
| Change in mathematical reserves and other life technical reserves | 0 | 0 |
| Change in deferred acquisition costs | 0 | 0 |
| Change in provisions | -1,525,122 | 35,153 |
| Non-monetary income and expenses deriving from financial instruments, | ||
| investment property and equity investments | -974,308 | 295,035 |
| Other changes | -1,062,107 | 6,735,779 |
| Change in receivables and payables generated by operating activity | -24,412,796 | 971,656 |
| Change in receivables and payables deriving from direct insurance and reinsurance operations | ||
| -20,088,148 | -12,123,045 | |
| Change in other receivables and payables | -4,324,648 | 13,094,701 |
| Taxes paid | -7,092,361 | 403,248 |
| Net cash generated/utilised by monetary items related to investment and financial activity | 35,047,874 | -37,730,462 |
| Liabilities from financial contracts written by insurance companies | 0 | 0 |
| Payables to bank customers and interbank payables | 0 | 0 |
| Loans and receivables from bank customers and interbank loans and receivables | 0 | 0 |
| Other financial instruments measured at fair value through profit or loss | 35,047,874 | -37,730,462 |
| TOTAL NET CASH FROM OPERATING ACTIVITIES | 32,421,468 | -39,912,509 |
| Net cash generated/utilised by investment property | 0 | 0 |
| Net cash generated/utilised by equity investments in subsidiaries, associates and joint ventures | 1,000 | -1,000 |
| Net cash generated/utilised by financial assets | ||
| measured at amortised cost | 3,983,987 | -8,000,016 |
| Net cash generated/utilised by financial assets | ||
| at fair value through OCI | -40,769,353 | -141,464,620 |
| Net cash generated/utilised by tangible and intangible assets | -15,611,158 | -91,230,257 |
| Other net cash flows generated/utilised by investment activities | 0 | 60,336,257 |
| TOTAL NET CASH FROM INVESTMENT ACTIVITY | -52,395,524 | -180,359,636 |
| Net cash generated/utilised by equity instruments attributable to the Group | -1 | 230,100,000 |
| Net cash generated/utilised by own shares | -1,247,111 | 0 |
| Distribution of dividends attributable to the Group | 0 | 0 |
| Net cash generated/utilised by subordinated liabilities and participating financial instruments |
0 | 0 |
| Net cash generated/utilised by liabilities measured at amortised cost | 13,479,796 | 2,567,991 |
| TOTAL NET CASH FROM FINANCING ACTIVITY | 12,232,684 | 232,667,991 |
| Effect of foreign exchange gains/losses on cash and cash equivalents | 0 | 0 |
| CASH AND CASH EQUIVALENTS AT START OF YEAR | 12,395,846 | 0 |
| INCREASE (DECREASE) IN CASH | ||
| AND CASH EQUIVALENTS | -7,741,372 | 12,395,846 |
| CASH AND CASH EQUIVALENTS AT END OF YEAR | 4,654,474 | 12,395,846 |

43 TABLE OF CONTENTS | Schedules attached to the notes to the financial statements

REVO Insurance S.p.A. is a newly incorporated joint stock insurance company created by the reverse merger between REVO S.p.A. (SPAC – special purpose acquisition company) and Elba Assicurazioni S.p.A., having its registered office at Via dell'Agricoltura 7, Verona, VAT No. 05850710962 and entered in the Verona Companies Register.
REVO was created by the reverse merger on 21 November 2022 of REVO SPAC and Elba Assicurazioni S.p.A., an insurance company operating in the insurance market since 2008.
Since that date, the Company has been listed on the Euronext STAR market organised and managed by Borsa Italiana S.p.A. In May 2022, REVO Underwriting S.p.A. (MGA) was established to provide insurance brokerage and advisory services as an agency authorised to write, issue and manage insurance policies, under licences and authorisations held by the insurance company, as well as its risk capital.
The Company, together with the subsidiary, REVO Underwriting S.r.l., forms the REVO Insurance Group, registered in the IVASS register under No. 059.
These financial statements have been prepared pursuant to ISVAP Regulation No. 7 of 13 July 2007 and have been prepared in accordance with applicable legal provisions, according to the valuation criteria and international accounting standards referred to below, and corresponding to the accounting records that reflect the transactions carried out by the Revo Insurance Group (hereinafter also the "Group") at 31 December 2022, supplemented by internal management data not directly identifiable in the accounts.
They have been prepared on a going concern basis and according to the accounting standards applied in the previous year, to ensure the comparability of the data.
The data for 2022 of the REVO Insurance Group are compared, for comparison with the 2021 financial year, with the data for the consolidated entity at that time, comprising REVO SPAC and Elba Assicurazioni S.p.A.
Amounts are shown in thousands of euro, unless expressly specified.

Pursuant to Legislative Decree No. 38/2005, REVO Insurance S.p.A. has prepared the consolidated financial statements as at 31 December 2022 in accordance with Legislative Decree No. 209 of 7 September 2005 (Italian Private Insurance Code) in force on the reporting date and ISVAP Regulation No. 7 of 13 July 2007, as amended, and in accordance with the international accounting standards (IAS/IFRS) issued by the IASB and endorsed by the European Union pursuant to Regulation (EC) No. 1606 of 19 July 2002 and Legislative Decree Nos. 38/2005 and 209/2005.
These financial statements consolidate the financial statements of REVO Insurance S.p.A. as at 31 December 2022 and of REVO Underwriting S.r.l. (in the case of the latter, only for the period from 3 May 2022 (the date of incorporation of the company) to 31 December 2022).
The consolidated financial statements have been prepared on a going concern basis, according to the accrual principle and the principles of relevance and reliability of accounting information, in order to provide a true and fair view of the financial position, cash flows and results of operations.
The going concern principle is considered to be confirmed with reasonable certainty, as it is believed that the companies belonging to the REVO Insurance Group have adequate resources to ensure the continuity of operations in the foreseeable future.
The consolidated financial statements have been prepared in accordance with:
The unit of account used is the euro. All amounts shown in the notes are expressed in thousands of euro, unless otherwise indicated, for a better representation of the data.
The Group consolidated financial statements have been audited by the External Auditor, KPMG S.p.A., charged with auditing the consolidated financial statements for financial years 2017-2025.
These financial statements have been prepared in accordance with ISVAP Regulation No. 7/2007 and comprise:
They are accompanied by the Directors' Report on Operations, drawn up in accordance with Article 100 of Legislative Decree No. 209/05 and Article 2428 of the Italian Civil Code.
The reporting date of the consolidated financial statements is 31 December 2022, which is the closing date of the financial statements of the Parent Company, REVO S.p.A.
All of the companies included in the scope of consolidation close their financial statements on 31 December.
No significant events occurred after the end of the financial year that could affect the figures in the financial statements.
The scope of consolidation includes the financial statements of the Parent Company, REVO S.p.A., and those of its direct or indirect subsidiaries.
At 31 December 2022, the scope of consolidation exclusively included REVO Underwriting S.r.l., which is wholly owned by REVO Insurance S.p.A.

The consolidation method for subsidiaries provides for the full control, from the date of acquisition, of the assets, liabilities, income and expenses of the consolidated companies. By contrast, the carrying amount of the equity investment is eliminated with the corresponding share of the shareholders' equity of each subsidiary, showing, in the case of equity investments of less than 100%, the share of shareholders' equity and profit for the year pertaining to non-controlling interests.
The differences resulting from this operation, if positive, are recognised – after allocation to the assets or liabilities of the Subsidiary, including intangible assets – as goodwill under intangible assets.
Any negative differences are recognised in the income statement.
With regard to intercompany transactions, when preparing the consolidated financial statements, receivables and payables between the companies included in the scope of consolidation are de-recognised, as are income and expenses relating to transactions between the companies themselves, and gains and losses arising from transactions between such companies and not yet realised with Group third parties.
The financial statements of the Group companies used for the preparation of the consolidated financial statements are those approved by the Shareholders' Meetings or, if not yet approved, those prepared and approved by the respective Board of Directors.
The international accounting standard that governs share-based payments is IFRS 2. This standard defines a share-based payment transaction as a transaction in which the company receives goods or services from a supplier (including employees and financial advisors) under a share-based payment agreement.
This agreement confers the right to receive cash or other assets of the company in amounts based on the price (or value) of the equity instruments of the entity or another Group entity, or to receive equity instruments of the entity or another Group entity, provided that the specified vesting conditions, if they exist, are met.
In view of the difficulty in reliably assessing the fair value of services received based on the value of shares, reference is made to the fair value of the financial instrument, with the expense recognised over the vesting period. The obligation assumed by the company may be settled by delivery of own financial instruments ("equity-settled") or by delivery of cash and/or financial instruments of other entities ("cash-settled").
The Group settles the obligation through the former configuration, with a contra-entry in equity for the expense, thus without generating either a decrease in the equity value or monetary effects in the income statement.
In accordance with IAS 33, basic earnings per share are calculated by dividing the net profit attributed to shareholders holding ordinary shares of REVO Insurance S.p.A. by the weighted average of the ordinary shares outstanding during the year.
Diluted earnings per share are calculated by dividing the net profit attributed to shareholders holding ordinary shares by the weighted average of any additional ordinary shares that would be outstanding in the event of the conversion of all potential ordinary shares with dilutive effect. In the event of a negative result of operations, a loss (basic and diluted) per share is calculated.
In accordance with IAS 21, items denominated in foreign currencies are managed according to multi-currency accounting principles.

Monetary items in foreign currencies (currency units held and assets or liabilities to be collected or paid out as a number of fixed or determinable currency units) are converted using the exchange rate prevailing at the reporting date. Foreign exchange differences deriving from the settlement or valuation of monetary items are recognised in the income statement. At 31 December 2022, the Group did not hold any non-monetary assets denominated in foreign currencies.
In May 2020, the IASB issued amendments to IFRS 3 without changing the accounting requirements for business combinations. These amendments are effective as of 1 January 2022. The Group does not expect the adoption of these amendments to have any material impacts.
In May 2020, the IASB issued amendments to IAS 16. The amendments prohibit an entity from deducting from the cost of property, plant and equipment the amounts received from the sale of items produced while the entity is preparing the asset for its intended use. Instead, an entity should recognise these sale proceeds and their cost in the income statement. These amendments are effective as of 1 January 2022.
In May 2020, the IASB issued amendments to IAS 37, specifying which costs an entity includes when assessing whether a contract will be onerous. These amendments are effective as of 1 January 2022.
Annual improvements that make minor amendments to IFRS 1 - First-time Adoption of International Financial Reporting Standards, IFRS 9 - Financial Instruments, IAS 41 - Agriculture and the illustrative examples accompanying IFRS 16 - Leasing.
The following new standards, amendments and interpretations have been issued by the International Accounting Standards Board (IASB) and adopted by the European Union, and will become mandatory from 2023 or in subsequent years:
The following section has been prepared on the basis of instructions issued by ESMA (European Securities and Markets Authority) in a note published on 13 May 2022, on transparency on implementation of the new IFRS 17 (hereinafter "the Standard"), and according to the contents of the joint press release of 27 October 2022 issued by IVASS, Banca D'Italia and Consob on the information to be provided in the file of financial statements as at 31 December 2022 in order to comply with paragraphs 30-31 of IAS 8.
It should be noted that the quantitative information presented below is to be considered preliminary, since the transition phase to the new accounting standard is being finalised and refined.
The impact of adoption of the new standard will be presented with the following details:

IFRS 17 - Insurance Contracts was created with the aim of introducing greater transparency and clarity of information to stakeholders, defining the principles to be applied for the recognition, measurement and accounting of all insurance and reinsurance contracts, through:
The main changes introduced for the purposes indicated above relate to:
If the Full Retrospective Approach cannot be applied, the Standard allows either one of the following two methods to be used:

The definition of an insurance contract set out in the new standard is the same as the definition established by the previous standard, IFRS 4. The scope of application is therefore essentially unchanged and includes:
If an insurance contract includes one or more components with non-insurance characteristics that, if considered individually, would fall within the scope of application of other international standards (this is the case for some contracts that include both insurance and the provision of goods and services8), unbundling, i.e. the breaking down of the contract into its components will be necessary, with the relevant recognition of these components according to other standards.
In light of the analyses carried out, both in terms of the classification of insurance contracts and in consideration of the criteria for the separation of non-insurance components, the Group does not expect any impact from the scope of application of IFRS 17 in addition to its current requirements and application under IFRS 4.
Specifically, all the contracts in the Group's portfolio fall within the definition of insurance contracts.
The Standard establishes that, for the purposes of measurement, insurance and reinsurance contracts must be aggregated into contract groups with uniform characteristics. In principle, these groups are grouped together in portfolios that represent a set of contracts with similar risks, for which the legislation allows joint management and which are subsequently divided into annual cohorts on the basis of the year the contract was signed.
Each annual cohort is valued according to the Onerous Contract Test, which enables them to be divided into three subgroups:
In valuing its contracts, the Group has divided the business into the 20 different contract groups listed below:
8 Example: roadside assistance policies, which may fall under the definition of IFRS 15.

This subdivision reflects the business lines currently marketed by the Group and allows for activities to be represented in line with the segmentation already used for the purposes of other business valuations (pricing, planning, Solvency II, etc.), thus achieving valuation synergies as well as consistent business vision and assessment models.
The portfolios have been divided into 11 contract groups, which represent a set of similar risks managed jointly. The company's portfolios are as follows:
The table below shows the classification of business within the above contract groups and portfolios:
| IFRS 17 portfolio | Contract group - REVO LoB | ||
|---|---|---|---|
| Engineering | |||
| Property | Property | ||
| FI | |||
| Indirect Property | Property Cat | ||
| Parametric Cat | |||
| Parametric | Parametric Agro | ||
| Parametric Financial Loss | |||
| Accident & Health | PA | ||
| Other Motor | Land Vehicles | ||
| Aviation | |||
| MAT Specialty Lines | FA&S | ||
| Marine | |||
| Liability | |||
| PI | |||
| General Liability | D&O | ||
| Cyber | |||
| Credit | Credit | ||
| Agro | Agro | ||
| Suretyship | Bond | ||
| Miscellaneous | Protection |
With regard to the allocation of portfolios to profitability buckets, the Group has defined a specific Onerous Contract Test, carried out, as permitted by the Standard, for each contract group with the same characteristics,
identified in the table above as Revo LoB. The test, carried out at initial recognition of contract groups, enables a Combined Ratio (CoR) to be obtained that also takes into account the risk adjustment component, and is then compared with the value of the thresholds selected by the Company, which are shown below:

profitable, if CoR ≤ 95%
As already mentioned, under the Standard, insurance contracts can be measured using three models: the General Model (GM), the Premium Allocation Approach (PAA) and the Variable Fee Approach (VFA).
Due to the nature of the contracts written, the Group does not use the VFA method as a measurement model for insurance liabilities.
The value of insurance liabilities, according to the Standard, consists of the sum of two components:
The LFRC includes cash flows relating to insurance services (payment of claims and expenses) that will be provided in future years and the expected profit on contractual services at the valuation date.
The LFIC includes cash flows relating to claims (and the relevant expenses) already incurred but not yet paid, including claims incurred but not reported.
The simplified PAA measurement model can be used to measure LFRC only and differs from the GM mainly due to the absence of the Contractual Service Margin and the option of implementing simplifications during the liabilities valuation phase.
Under the Standard, the valuation of the LIC component of insurance liabilities can only be carried out using the GM model.
At initial recognition, the Group will measure the value of financial liabilities as the sum of the following factors:
To calculate the Liability for Remaining Coverage, the Group favours the use of the PAA for all contracts, ascertaining beforehand, for contracts with a duration of more than one year, whether it is possible to applying the valuation model chosen on the basis of a quantitative analysis (the "eligibility test"), the results of which show that the effects on the Liability for Remaining Coverage deriving from the application of the Premium Allocation Approach represent a reasonable approximation of the value of the insurance liability obtained by applying the General Model.
By using the PAA method, LFRC is recognised in the income statement over the contractual coverage period. The Group has decided to adopt the pro-rata temporis method as its automatic choice for releasing liabilities. Accordingly, the method of recognising revenues will be similar to the accounting of the unearned premium reserve under IFRS 4.
Valuation using one of the measurement models set out above must include all cash flows established within the contractual limits ("contract boundaries") of each insurance contract in the reference group.
For groups of insurance contracts, initial recognition occurs when:
The Company includes in an existing group only contracts that individually meet one of the above criteria.
The cash flows included within the contract boundaries are those directly related to the fulfilment of the contract and those over which the Company has discretion. It was also decided to regard as annual contracts those that allow the Company to redefine the pricing of the contract at the end of each year of coverage, leveraging the Solvency II metrics.

According to the Standard, when determining the present value of future cash flows, cash flows must be measured by reflecting the time value of money and the associated financial risk. To this end, it is established that the discount rate must:
The Group uses a bottom-up approach in defining the discount rate, which involves the use of an appropriately adjusted risk-free curve (publicly provided by EIOPA), seeking to maintain consistency with the valuations performed for Solvency II purposes as far as possible.
Risk Adjustment is the compensation that the entity requires in order to withstand the uncertainty of financial cash flows (in terms of amount and time) due to non-financial risk.
Risk Adjustment is measured as a percentage calculated on the present value of future cash flows.
The Standard does not define a specific valuation method and, in this context, the Group considered the percentile approach to be an appropriate approximation for estimating the Risk Adjustment. The amount is therefore calculated using the Value at Risk method with a 75% confidence level.
The Contractual Service Margin represents the expected profit, not yet realised, recorded when the contract is written as an insurance liability and recognised in the income statement as and when the service is rendered, defined on the basis of a release pattern.
If the contract group, at initial recognition, is onerous (i.e. the difference between incoming and outgoing cash flows is negative), a loss must be recognised in the income statement equal to the net cash flow, resulting in an insurance liability equal to the amount of outflows and a Contractual Service Margin of zero.
At initial recognition, the Contractual Service Margin will be equivalent (in methodological and quantitative terms), in the case of application of either the General Model or the Variable Fee Approach. These models differ, however, in subsequent measurements. The Premium Allocation Approach does not provide for the establishment of the Contractual Service Margin. Its value will be equal to the difference between the present value of future cash inflows and outflows, adjusted for risk.
After the date of initial recognition, the carrying amount of the Contractual Service Margin of the contract group must be recalculated at each reporting date, in order to reflect the profit on a contract group that has not yet been recognised in the income statement.
The carrying amount of the Contractual Service Margin of a contract group at the end of the period is equal to its carrying amount at the start of the period, adjusted for:

the amount of the Contractual Service Margin recognised in the income statement relating to the provision of insurance services during the reporting period.
If the changes in future cash flows described above, relating to future insurance services, exceed the Contractual Service Margin, the CSM will be reduced to zero and a loss component will be simultaneously recorded in the income statement.
For the calculation of the LFRC, the Group prefers to use the PAA for the entire marketed business, which does not require an estimate of the CSM.
The transition date is the date of commencement of the annual reporting period immediately preceding the date of firsttime adoption of the Standard, i.e. 1 January 2023, the date from which the business is valued according to IFRS 17 metrics. At the transition date, IFRS 17 requires that the Group, for contracts valued according to the General Model level at LFRC level, identify, recognise and measure each group of insurance contracts in existence as if IFRS 17 had been applied at the time of their initial recognition (Full Retrospective Approach or FRA) in order to identify the CSM. The FRA requires numerous data and information to be available on a UoA basis. This may mean that the method cannot be applied, because information is lacking and cannot be reconstructed retrospectively or would entail higher costs than the benefits that the reader of the financial statements would gain.
If, and only if, the Full Retrospective Approach proves impracticable, the Standard authorises the application of alternative methods for the purposes of valuing assets at the transition date:
In accordance with IFRS 3, in November 2021 the Group carried out a Purchase Price Allocation (PPA) that led to the measurement at fair value of insurance assets and liabilities held through the recognition of the value of business acquired (VoBA). Therefore, to measure the CSM at the transition date using the Fair Value Approach, the Group uses these approaches, exploiting any synergies with the above activity that it already performs.
The following table provides an estimate of the impacts of application of IFRS 17 on the opening (1 January 2022) and closing (1 January 2023) consolidated statements of financial position:
| impact of IFRS 17 vs IFRS 4 - € 000 | 01.01.2023 | 01.01.2022 |
|---|---|---|
| Shareholders' equity attributable to the Group (before tax) under IFRS 4 | 216,632 | 218,478 |
| Impact on shareholders' equity (before tax) - Application of IFRS 17 | -1,600 to +700 | -2,600 to -300 |
| Impact on shareholders' equity attributable to the Group (after tax) | -1,100 to +500 | -1,800 to -100 |
| Profit for the period (after tax) under IFRS 4 | 5,316 | 13,842 |
| Impact on profit for the period (after tax) | +1,000 to +400 | - |
At the time of first-time adoption (initial application of the Standard), for the purposes of determining insurance liabilities, the Group determined that, as the business is valued using the Premium Allocation Approach for both insurance contracts written and reinsurance contracts ceded, IFRS 17 does not provide for the calculation of the Contractual Service Margin, only for any loss component, if the contract group is onerous. Therefore, at the time of first-time adoption, the liability for remaining coverage (net of any loss component) will be equivalent to the premium reserve under IFRS 4.

In January 2020, the IASB issued amendments to IAS 1 to clarify how to classify payables and other liabilities as current or non-current and, in particular, how to classify liabilities with and uncertain settlement dates and liabilities that can be settled through conversion to equity. These amendments will take effect on 1 January 2023. The Group does not expect the adoption of these amendments to have any material impacts.
In February 2021, the IASB issued amendments to IAS 1, requiring entities to provide their material accounting policy information, rather than significant accounting policies, and providing guidance on how to apply the concept of materiality to the disclosure of accounting policies. These amendments will take effect on 1 January 2023. The Group does not expect the adoption of these amendments to have any material impacts.
In February 2021, the IASB issued amendments to IAS 8, clarifying that entities are to distinguish changes in accounting policies from changes in accounting estimates. These amendments will take effect on 1 January 2023. The Group does not expect the adoption of these amendments to have any material impacts.
In May 2021, the IASB issued amendments to IAS 12 to clarify how entities should account for deferred tax liabilities on transactions such as leases and decommissioning obligations, transactions for which entities recognise both an asset and a liability. In particular, it was clarified that the exemption does not apply and that entities are required to recognise deferred taxation on such transactions. These amendments will take effect on 1 January 2023, with early adoption permitted. The Group does not expect the adoption of these amendments to have any material impacts.

Intangible assets In accordance with IAS 38, an intangible asset is only recognised if it is identifiable, controllable, and it is foreseeable that it will generate future economic benefits and its cost can be reliably determined, while it does not include deferred acquisition costs, which must be included in the relevant item 6.2 "Other assets".
This category includes goodwill and other intangible assets.
Goodwill represents the excess of the purchase cost over the acquirer's share of the fair value of the acquiree's identifiable net asset and liability values. The purchase cost includes costs directly associated with the transaction.
After initial recognition, goodwill is valued at cost less any cumulative impairment losses. Goodwill is tested for impairment on an annual basis, in order to prevent any impairment. Verification of the adequacy of goodwill is intended to identify the existence of any impairment of the value recorded as an intangible asset.
Cash generating units (CGUs), to which the goodwill is to be allocated, are first identified. Any impairment is equal to any negative difference between the value previously recognised and its recoverable amount. The latter is determined as the greater of the fair value of the cash-generating unit and its value in use, which is equal to the discounted future cash flows of the unit. If the reason for a previous write-down no longer exists, the carrying amount cannot be increased.
Intangible fixed assets with a finite useful life are measured at purchase cost or production cost net of amortisation and impairment. Amortisation must be calculated on the basis of useful life, starting from the time when the asset is available for use.
Meanwhile, other intangible fixed assets with an indefinite life are not subject to amortisation but are periodically checked for impairment.
The account also includes intangible assets under construction and advances paid for the acquisition of intangible assets, although they cannot be amortised.
The goodwill paid to acquire portfolios (VoBA), the amount of which is determined by estimating the present value of the future profits of the contracts in place at the time of acquisition, is included in other intangible assets. It consists of the difference between the carrying amount of technical provisions net of reinsurance valued in accordance with IFRS 4 and the corresponding fair value. The VoBA is amortised on the basis of the actual life of the contracts acquired.
In accordance with IAS 16, land and buildings destined for use by the Company are recorded in this category. Property is recognised at purchase cost net of depreciation and impairment. Directly attributable costs incurred to get the asset into the condition necessary for its operation according to business requirements are included.
Ordinary maintenance costs are charged directly to the income statement. Costs incurred after purchase are capitalised only if they can be reliably determined and if they increase the future economic benefits of the assets to which they relate; other costs are recognised in the income statement.
Depreciation using the straight-line method is charged over the estimated useful life of properties, ranging from 30 to 50 years.

Maintenance costs that are not ordinary in nature, improvements and transformations that result in an increase in the value, functionality or useful life of the assets, are directly capitalised, allocated to the assets to which they refer and depreciated. Ordinary maintenance and repair costs are charged to the income statement.
Property is tested for impairment by comparing its carrying amount with its estimated fair value, determined according to specific appraisals. Impaired property assets are written down as required. This item includes operating properties, plant, other machinery and equipment and other tangible assets. This category includes property and other tangible assets.
This item includes property assets, furnishings and office machinery.
These are recorded, as established by IAS 16, at purchase cost and subsequently recognised net of depreciation and any impairment. The determination of cost includes ancillary costs and directly attributable costs, incurred to get the asset to the place and into the condition necessary for its operation according to business requirements. They are systematically depreciated on the basis of economic/technical rates determined in relation to the residual possibility of use.
The depreciation rates are 50% lower for purchases that took place during the year, compared with the rates indicated below, which apply from the year after the first year:
| Rate | |
|---|---|
| Furniture and fixtures | 12% |
| Plant | 15% |
| Other equipment | 20% |
| Electronic machinery | 20% |
| Movable property entered in public registers | 25% |
Repair costs and ordinary maintenance costs are charged to the income statement for the year in which they are incurred. Subsequent costs, which can be reliably determined and which increase the future economic benefits of the asset are capitalised and depreciated according to the remaining useful life of the asset to which they relate.
Pursuant to IAS 36, tangible assets are subject, at least once a year, to impairment testing (recognising as a loss the negative difference between the carrying amount and the recoverable amount) and to checks on the adequacy of their remaining useful life.
If the recoverable amount is lower than the carrying amount, an impairment loss is recognised. If, subsequently, the loss no longer exists or is reduced, the carrying amount of the asset or cash generating unit would be increased up to the new recoverable value. However, this new value may not exceed the value determined prior to recognition of the loss.
The item in question includes reinsurers' obligations under reinsurance treaties, regulated by IFRS 4. The provisions are calculated using the same criteria as those used to allocate provisions for direct business, taking into account reinsurance contractual clauses.
IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the valuation date.
Allocation to one of the three fair value levels envisaged by IFRS 13 meets the following criteria:
Financial instruments quoted on an active market;
Financial instruments whose fair value has been determined on the basis of valuation techniques based on observable market parameters, other than the prices quoted for the financial instrument;

Financial instruments whose fair value has been determined on the basis of valuation techniques based on parameters not observable in the market;
Observable market variables and assumptions are favoured in the definition of fair value and measurement techniques are only used in the absence of such inputs.
These valuation methods must be applied in hierarchical order: if, in particular, an active market price is available, no other valuation approach can be used.
In summary, first the prices quoted on active markets for the same or identical financial instruments were examined, then the inputs for the asset or liability, observable both directly and indirectly, and finally the inputs relating to the asset or liability that are not based on observable market data.
In accordance with IAS 40, the Group considers investment property to be assets held with the objective of receiving rental payments or achieving the aim of appreciating the invested capital, or both.
Investments intended for use by the Company or for sale in the ordinary course of its business are classified under "Tangible assets".
Investment property is recorded at cost, less depreciation and any impairment. The determination of cost includes ancillary costs and directly attributable costs incurred to get the asset into the condition necessary for its operation according to business requirements.
Depreciation is charged on a straight-line basis over the estimated useful life of the assets.
Land, which is assumed to have an unlimited useful life, is not included in the depreciation process. In order to carry out the different accounting treatment, land and buildings are recorded separately, even if they were purchased together.
Repair costs and ordinary maintenance costs are charged to the income statement for the year in which they are incurred. Subsequent costs, which can be reliably determined and which increase the future economic benefits of the asset, are capitalised and depreciated according to the remaining useful life of the asset to which they relate.
Pursuant to IAS 36 - Impairment of Assets, investment property is tested for impairment by comparing the carrying amount with the estimated fair value, determined through specific appraisals. Any negative difference is recognised in the income statement.
The Group does not have any investment property.
This item includes equity investments in subsidiaries, associates and joint ventures, regulated by IFRS 10, IAS 28 and IFRS 11, that are not classified as held for sale in accordance with IFRS 5.
A company is defined as an associate when the investor exercises significant influence, having the power to participate in determining the investee's operational and financial decisions, without holding control or joint control. Significant influence is presumed to exist if the investor possesses, directly or indirectly, at least 20% of the votes exercisable at the shareholders' meeting.
Joint ventures are equity investments in joint arrangements in which the parties have rights to the assets and assume obligations for the liabilities relating to the arrangement; they differ from joint operations, which exist when joint control of an economic activity is contractually agreed, i.e. when decisions on the relevant activities require the unanimous consent of the parties that share control. Regardless of the legal form of the investee, the assessment of control takes into account the actual power over the investee and the actual ability to influence the relevant activities, regardless of the number of voting rights.
The measurement criterion adopted by the Group is the ' equity method, i.e. the accounting method by which the equity investment is initially measured at cost and subsequently adjusted as a result of changes in the investor's share of the investee's net assets The profit or loss of the investor reflects its share of the profit or loss for the year of the investee, as per the last approved accounting statement.
This category includes financial assets that meet both of the following conditions:

Initial recognition of the financial asset occurs at the settlement date for debt securities and at the disbursement date for loans. On initial recognition, assets are recorded at fair value, including transaction costs or income directly attributable to the instrument.
After initial recognition, loans and receivables are measured at amortised cost, which is equal to their initial value increased or decreased by principal repayments, adjustments or write-backs and amortisation calculated using the effective interest rate method of the difference between the amount disbursed and the amount to be repaid at maturity, typically related to the costs and income directly attributable to the individual loan or receivable.
The amortised cost method is not used for loans or receivables, for which the effect of application of the discounting approach may be deemed negligible due to their short durations. Such loans or receivables are measured at their historical cost.
The basis of valuation is closely connected to the inclusion of the instruments in question in one of the three stages (stages of credit risk) provided for in IFRS 9, the last of which (Stage 3) includes non-performing financial assets and the remaining performing financial assets (Stages 1 and 2).
If the grounds for impairment cease to apply as a result of an event that occurs after an impairment loss has been recognised, a write-back is made in the income statement. The write-back may not exceed the amortised cost that the financial instrument would have had in the absence of previous adjustments.
This category includes financial assets that meet both of the following conditions:
This item also includes equity instruments not held for trading, for which the option of designation at fair value through other comprehensive income was exercised on initial recognition.
In particular, this item includes:
On initial recognition, assets are recorded at fair value, including transaction costs or income directly attributable to the instrument.
After initial recognition, assets classified at fair value through other comprehensive income, other than equity securities, are measured at fair value, with the impacts of the application of amortised cost, impairment and any foreign exchange effect recognised in the income statement, while other gains or losses deriving from a change in fair value are recognised in a specific equity reserve until the financial asset is de-recognised. At the time of full or partial disposal, the gain or loss accumulated in the valuation reserve is reversed in the income statement.
Equity securities classified at fair value through other comprehensive income are measured at fair value, with the recognition of valuation effects in shareholders' equity and the recognition of dividend income in the income statement.
Financial assets are de-recognised only when the contractual rights to the associated cash flows expire or when the financial asset is sold with the substantial transfer of all the risks and rewards associated with the assets.
This item includes financial assets not classified as financial assets measured at amortised cost or at fair value through other comprehensive income, and, in particular:
financial assets held for trading;

This item includes trade receivables deriving from direct insurance and reinsurance operations and other receivables. Other receivables are recognised at their nominal value and are subsequently measured at their estimated realisable value. Amortised cost was not applied as the application of this criterion would be practically the same as the historical cost and, when determining the recoverable value, no cash flows were discounted, which would yield completely negligible results.
This item includes receivables from policyholders for premiums not yet collected, and from insurance agents and brokers.
These are receivables from reinsurance companies or insurance companies relating to reinsurance relationships. They are recognised at their nominal value and subsequently measured at each reporting date at their estimated realisable value.
Other receivables include tax credits and miscellaneous receivables that are not insurance-related. They also include advances paid to third parties. They are recognised at their nominal value and subsequently measured at their estimated realisable value and discounted where appropriate.
Non-current assets, current and deferred tax assets and other assets are classified under this item.
Non-current assets or disposal groups held for sale are recognised under this item in accordance with IFRS 5. Non-current assets and disposal groups are classified as held for sale if their carrying amount is recovered mainly through a sale transaction rather than through their ongoing use. This condition is considered fulfilled only when a sale is highly probable and the discontinued asset or group is available for immediate sale in its current condition. Assets are recognised at the lower of their carrying amount and their fair value, net of foreseeable costs to sell. The resulting profit or loss, after tax, is presented separately in the statement of comprehensive income.
In accordance with IFRS 4, acquisition costs paid in advance at the time of signing multi-year contracts are recognised under this item, to be amortised within the maximum term of the contracts. In accordance with IFRS 4, local accounting standards are used to account for such costs.
These items include assets relating to current and deferred taxes, as defined and regulated by IAS 12. These assets are recognised in accordance with current tax legislation and are recognised on an accruals basis. For tax assets recognised as deferred taxes, a check is periodically carried out on each reporting date for any changes in the relevant tax legislation that might determine a different valuation.
Other assets include accrued income and prepaid expenses, in addition to other residual assets that are not included in the above items, and in particular claims in the process of payment.

This item includes cash and cash equivalents and deposits that are available on demand. These are recognised at nominal value.

Ordinary shares and preference shares are recorded as share capital and their value corresponds to the nominal value actually paid.
This item includes equity instruments not included in the share capital, consisting of special classes of shares, as well as equity components included in complex financial instruments.
These include the equity reserves of the companies that have been consolidated and the share premium reserves.
In particular, this item includes:
Any gains or losses due to fundamental errors and changes in accounting standards or the estimates used are included (IAS 8).
As specified by IAS 32, this item includes the equity instruments of the company that prepares the consolidated financial statements held by the company itself and by the consolidated companies. The item is negative. Gains or losses deriving from their subsequent sale are recognised as changes in shareholders' equity.
This item includes foreign exchange differences deriving from transactions in foreign currencies and from translation of financial statements into a presentation currency, in accordance with IAS 21.
This item includes gains or losses from financial assets measured at fair value through other comprehensive income, as previously described in the corresponding financial investments item. Amounts are shown net of corresponding deferred taxes and the share attributable to policyholders.
This item includes gains and losses recognised directly in shareholders' equity, with particular reference to the reserve deriving from changes in the shareholders' equity of investee companies, that said companies have not recognised in their income statements.

This item shows the consolidated result for the period.
The macro-item comprises equity instruments and components and the relevant equity reserves attributable to noncontrolling interests.
The Group does not have any shareholders' equity attributable to non-controlling interests.
In accordance with IAS 37, provisions are liabilities of uncertain amounts or maturities that are recognised under the following conditions:
Measurement of the values representing the obligation is reviewed periodically. Any change in the estimate is recognised in the income statement in the period in which it occurs.
Commitments arising from insurance contracts and financial instruments with discretionary participation features (DPF) gross of reinsurance are classified in this macro-item.
Under IFRS 4, insurance contracts are contracts that transfer material insurance and financial risks. An insurance risk is material if, and only if, there is a reasonable possibility that the occurrence of the insured event will cause a significant change in the present value of the insurer's net cash flows.
The unearned premiums reserve is calculated on a pro-rata temporis basis according to taxable premiums written, minus acquisition commissions and other directly attributable acquisition expenses. The premium reserve for risks in progress was zero this year.
For the Suretyship class, the unearned premiums reserve is supplemented in accordance with ISVAP Regulation No. 16/2008. For the purposes of the consolidated financial statements, in accordance with the requirements of IFRS 4, the additional suretyship reserve was calculated for contracts still live at the valuation date.
The claims reserve is determined, in accordance with IFRS 4 and the provisions of ISVAP Regulation No. 16 of 4 March 2008 and Annex No. 15 to ISVAP Regulation No. 22 of 4 April 2008, as amended by IVASS Order No. 53 of 6 December 2016, on the basis of an analytical estimate of the individual cases based on a prudent and objective assessment of the documentation received regarding claims that occurred during the year or in previous years and not yet paid, by estimating the provision for late claims on the basis of an analysis of the information available.
The total amount set aside is deemed appropriate to meet the future payment of claims, direct expenses and settlement expenses.
This item includes financial liabilities regulated by IFRS 9 other than payables.
This item includes financial liabilities at fair value through profit or loss, and specifically:

This item includes financial liabilities, including investment contracts written by insurance companies, other than indexand unit-linked contracts, as reinsurance deposits do not fall within the scope of IFRS 4.
Payables include payables deriving from reinsurance operations and other payables, such as trade payables, taxes payable by policyholders, payables for severance indemnities, payables for miscellaneous tax charges and payables to social security and pension institutions. Payables are recognised at their nominal value.
This item includes payables deriving from insurance operations recognised at nominal value.
This item includes payables deriving from reinsurance operations recognised at nominal value.
This item specifically includes provisions for payables to employees for employee severance benefits, recognised in accordance with IAS 19.
This is in addition to other specific liabilities of certain existence which are not allocated to the previous sections of the financial statements.
In accordance with IFRS 5, liabilities relating to disposal groups held for sale are recognised under this item.
These items include liabilities relating to current and deferred taxes, as defined and regulated by IAS 12. These liabilities are recognised in accordance with current tax legislation and are recognised on an accruals basis. For liabilities recognised as deferred taxes, a check is periodically carried out on each reporting date for any changes in the relevant tax legislation that might determine a different valuation.
This item includes transition accounts, commissions for premiums in the process of collection, as well as accrued expenses and deferred income, determined according to the accrual principle.
A contract contains a lease if, in exchange for a consideration, it confers the right to control the use of a specified asset for a period of time.
For contracts in this category the right of use and the relevant financial liabilities are recognised, except in the following cases: short-term contracts (i.e. leases with a term of 12 months or less) or low-value assets (less than €5,000 when new). The right of use and the relevant financial liability deriving from the lease are recognised on the contract inception date Financial liabilities are initially determined at the present value of future payments at the contract inception date, discounted at the implicit rate of the lease or, if this is not readily determinable, at the lessee's incremental borrowing rate.

In subsequent entries, the amortised cost method is applied, i.e. the carrying amount of the liability is increased by the interest thereon and decreased to take account of payments made under the lease.
The value of the financial liability is recalculated (with a corresponding adjustment to the value of the right of use) in the following cases: a change in the term of the lease; a change in the value of the exercise of the option right; a change in the value of lease payments following changes in indices or rates; or changes in the amount of guarantees in line with the expected residual value. The value of the liability is redetermined by discounting the new lease payments at the initial discount rate (unless the lease payments change as a result of a fluctuation in variable interest rates, in which case a revised discount rate is used).
The right-of-use asset is initially measured at cost, which includes: the initial value of the liability deriving from the lease; and lease payments made before or on the inception date of the contract. In subsequent entries, the right of use is recognised in the financial statements net of depreciation and any impairment. Depreciation is on a straight-line basis over the period between the inception date of the contract and the shorter of the lease term and the residual useful life of the underlying asset.

The macro-item includes earned premiums relating to insurance contracts, net of reinsurance.
Premiums are recognised with reference to their time of accrual. With the recognition of the premium reserve, the accrual for the period is obtained.
IFRS 4 defines an insurance contract as a contract under which the insurer accepts significant insurance risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event adversely affects the policyholder. In fact, the insurance risk is transferred from the policyholder to the insurer, as well as the writer of the insurance contract.
Contracts within the scope of IFRS 4 are treated in accordance with the principles applicable to statutory financial statements. In accordance with Legislative Decree No. 173/1997 and ISVAP Regulation No. 22/2008, premiums include:
This item includes commission income for financial services provided that are not included in the calculation of the effective interest of a financial instrument.
It includes commissions relating to investment contracts not within the scope of IFRS 4, such as loading (explicit and implicit) and, for contracts that entail investment in an internal fund, management fees and other similar items.
The macro-item includes realised gains and losses and increases or decreases in the value of financial assets and liabilities measured at fair value through profit or loss.
This item includes income arising from equity investments in subsidiaries, associates and joint ventures recognised under the corresponding asset item. Specifically, it includes the share of the positive result for the year relating to Group companies, accounted for using the equity method.
The macro-item includes income deriving from financial instruments not measured at fair value through profit or loss. Specifically, the item includes interest income recognised on financial instruments measured using the effective interest method, other investment income and gains realised following the sale of a financial asset or liability.
This item includes interest income recognised using the effective interest method.
The Group recognises in this item revenues deriving from third-party use of investment property.
The macro-item includes:

The macro-item includes the amount paid in the period for claims, as well as the amount of changes in technical provisions relating to contracts under IFRS 4. This item includes reinsurance quotas with a corresponding value in reinsurance cessions deducted from net premiums.
This item includes commission expenses for financial services received that are not included in the calculation of the effective interest of a financial instrument. Specifically, this includes acquisition costs relating to investment contracts not falling within the scope of IFRS 4.
This item includes expenses arising from equity investments in subsidiaries, associates and joint ventures recognised under the corresponding asset item. Specifically, it includes the share of the positive result for the year relating to Group companies, accounted for using the equity method.
The macro-item includes expenses deriving from financial investments not measured at fair value. Specifically, interest expenses recognised using the effective interest criterion are included, and in particular losses realised following the elimination of a financial asset or liability and impairment. Additionally, it includes administrative expenses, including general and payroll expenses, related to the management of financial instruments. In particular, we include interest expense, other property-related expenses, capital losses on the sale of securities, and lastly the write-downs of bonds of issuers in technical default.
This item includes interest expense recognised using the effective interest criterion on financial liabilities.
This item includes, inter alia, costs relating to investment property, particularly service charges and maintenance and repair costs not included in the increase in value of the investment property.
The item includes losses realised due to the elimination of a financial asset or financial liability.
This item includes decreases deriving from financial assets and liabilities measured at fair value through profit or loss.
The macro-item includes commissions, acquisition expenses, administrative expenses relating to contracts within the scope of IFRS 4 and expenses relating to contracts. It also includes payroll expenses of companies engaged in activities other than insurance and general and payroll expenses relating to investment operations.
This item includes acquisition costs, net of reinsurance, relating to insurance contracts and financial instruments pursuant to IFRS 4.

This item includes general and payroll expenses relating to the management of financial instruments, investment property and equity investments.
This item includes general and payroll expenses not allocated to claims-related expenses, expenses for acquiring insurance contracts and investment management expenses.
Other costs include other technical expenses for insurance contracts, provisions for the year, realised losses, impairment and depreciation/amortisation of both tangible and intangible assets.
Current taxes for the year are included in this item.
The schedule includes income components other than those that make up the income statement, recognised directly in shareholders' equity for transactions other than those carried out with shareholders.
In accordance with ISVAP Regulation No. 7 of 13 July 2007, revenue and cost items are shown net of the relevant tax effects.
The result of the statement of comprehensive income is presented in the statement of changes in shareholders' equity.
As required by ISVAP (now IVASS) Regulation No. 7 dated 13 July 2007, the schedule shows all changes in shareholders' equity. In particular:
The table was prepared using the indirect method and in accordance with ISVAP Regulation No. 7 of 13 July 2007, distinguishing between operating, investment and financing activities.
In accordance with IAS/IFRS, the preparation of financial statements requires the Group to make use of estimates that affect the values of the assets and liabilities recorded, as well as the disclosure of contingent assets and liabilities.
For the 2022 financial statements, the assumptions made are believed to be congruous and appropriate and the financial statements are believed to be prepared clearly, providing a true and fair view of the financial position, cash flows and results of operations for the year.
Reference was made to historical experience and other reasonable factors in formulating reliable estimates. In particular, estimates were used relating to:

These estimates are reviewed periodically and the effects of changes are reflected in the income statement. The following chapters provide the analyses required by paragraphs 38 and 39 of IFRS 4, and specifically:
This is qualitative and quantitative information relating to the exposure to credit, liquidity and market risk deriving from the use of financial instruments, as well as sensitivity analyses, which highlight the impact of changes in the main financial and insurance variables.

Intangible assets
| Intangible assets | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Goodwill | 74,323 | 74,323 | - |
| Other intangible assets | 17,805 | 16,298 | 1,507 |
| Total | 92,128 | 90,620 | 1,507 |
Intangible assets include start-up costs and other multi-year directly attributable costs and are recognised in the financial statements at purchase cost. They are amortised over five years on a straight-line basis according to their expected useful life, deemed appropriate to represent the residual useful life of the assets.
Goodwill paid for the acquisition of portfolios (VoBA) is included in other intangible assets. The amount is determined by estimating the present value of the future profits of the contracts outstanding at the time of acquisition. It consists of the difference between the carrying amount of technical provisions net of reinsurance valued in accordance with IFRS 4 and the corresponding fair value. The VoBA is amortised on the basis of the remaining life of the contracts acquired.
The amortisation accruing to each year has been recognised under "other costs" in the income statement.
No impairment losses have been recognised.
Goodwill, recognised following the acquisition by REVO SPAC of Elba Assicurazioni S.p.A. in November 2021, amounting to €74,323,000, is the same as in the previous year.
During the year, no potential indicators of impairment were observed and, in particular, no indicators of a failure to achieve the objectives set out in the Plan or material changes with negative effects for the Group from a technological, market, economic and regulatory viewpoint.
International accounting standard IAS 36 requires that goodwill be tested for impairment at least once a year to determine whether there is evidence that the carrying amounts of assets may not be fully recoverable.
The impairment testing process involves ascertaining whether there are any indicators that the assets may have become impaired and then determining the amount of any such losses. Impairment indicators can essentially be divided into two categories:
The portion of the purchase price of Elba Assicurazioni's equity investment, that is higher than the portion at current value (net fair value) of assets and liabilities, was accounted for as goodwill and represents a payment made in anticipation of future economic benefits deriving from assets that cannot be identified individually and recognised separately. The ancillary costs incurred during the acquisition were charged to the income statement during the year.
In light of the current structure of the REVO Group and future corporate developments, focused, from the point of view of business development, on traditional and parametric insurance, mainly relating to the SME segment, the CGU was identified as the operating business itself, as there are no individual organisational/functional units capable of autonomously producing cash flows independently of each other.

With regard to the determination of value in use, parameters, methodologies and criteria commonly used by operators for this type of assessment have been adopted, such as the methodology of excess capital distributable beyond a certain Solvency Ratio threshold identified within the Company's risk appetite system, the cost of capital and the perpetual growth rate "g", determined on the basis of methodologies commonly used for valuation and forward-looking results based on the latest available economic and financial projections with a time horizon of at least four years.
On the basis of these methodologies, the impairment tests performed at 31 December 2022 were successful and did not entail any need to make write-downs.
Specifically, the cost of capital was determined on the basis of the CAPM (Capital Asset Pricing Model), with particular reference to a beta coefficient attributable to European insurance companies operating in the non-life segment and an equity risk premium attributable to the Italian market. On the basis of these parameters and taking into account the particular start-up phase of the project, a cost of capital of 11.24% was identified, in addition to a nominal long-term growth rate "g" of 0.5%. For the purposes of quantifying potentially distributable capital, a Solvency Ratio threshold of 130% was identified.
A sensitivity analysis was also conducted, using broader values for the parameters described, including the cost of capital and the growth rate "g" (+/-0.5%) and the Solvency Ratio threshold (+/-10%): this analysis did not indicate any need to recognise any goodwill impairment.
Other intangible assets totalled €17,805,000 (€16,298,000 at 31 December 2021). The item includes:
The increase in the item relating to information systems was specifically due to the implementation of the strategic development plan, which provides for substantial IT investments to support and sustain the Company during the business development phase (in particular the change in the accounting management system in view of the introduction of the new IFRS 17 accounting standard and the development of the OverX platform, designed, inter alia, to simplify and facilitate underwriting processes).
| Intangible assets | Gross carrying amount at 31.12.2021 |
Accumulated amortisation at 31.12.2021 |
Change | Amortis ation |
Accumulated amortisation at 31.12.2022 |
Net carrying amount at 31.12.2022 |
|---|---|---|---|---|---|---|
| VoBA | 13,091 | -136 | -3,909 | -4,045 | 9,046 | |
| Other | 8,190 | -4,847 | 6,836 | -1,420 | -6,267 | 8,759 |
| Total | 21,281 | -4,983 | 6,836 | -5,329 | -10,312 | 17,805 |
It should be noted that in the consolidated financial statements as at 31 December 2021, other intangible assets also included third-party property rights relating to leases for Via Mecenate 90 and other secondary offices of €1,286,000, reclassified in 2022 under tangible assets, as required by IVASS Order No. 121 of 7 June 2022, amending ISVAP Regulation No. 7/2007.
| Tangible assets | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Property | 13,973 | - | 13,973 |
| Other tangible assets | 475 | 344 | 131 |
| Total | 14,448 | 344 | 14,104 |

At 31 December 2022, tangible assets, net of related accumulated depreciation, amounted to €14,448,000. The item includes:
Tangible assets are recognised at purchase cost and depreciated according to the rates below, which are considered appropriate to reflect the remaining useful life of the assets, in line with the Ministerial Decree of 1988.
The depreciation rates are 50% lower for purchases that took place during the year, compared with the rates indicated below, which apply from the year after the first year:
| Rate | |
|---|---|
| Furniture and fixtures | 12% |
| Plant | 15% |
| Other equipment | 20% |
| Electronic machinery | 20% |
| Movable property entered in public registers | 25% |
The following table shows a breakdown of changes in tangible assets during the year:
| Gross carrying amount at |
Accumulated depreciation |
Other | Accumulate d depreciation at |
Net carrying amount at |
|||
|---|---|---|---|---|---|---|---|
| Tangible assets | 31.12.2021 | at 31.12.2021 | Increases | changes9 | Depreciation | 31.12.2022 | 31.12.2022 |
| Property | - | - | 15,491 | -735 | -783 | -783 | 13,973 |
| Other tangible assets | 1,281 | -936 | 264 | - | -134 | -1,070 | 475 |
| Total | 1,281 | -936 | 15,755 | -735 | -917 | -1,853 | 14,448 |
| Reinsurers' share of technical provisions | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Premium reserve | 43,152 | 30,367 | 12,785 |
| Claims reserve | 12,584 | 9,528 | 3,056 |
| Total | 55,737 | 39,895 | 15,841 |
The reinsurers' share of technical provisions consists of the premium reserve (€43,152,000) and the claims reserve (€12,584,000).
The changes compared with the previous year mainly reflect the growth in the insurance business and the change in the reinsurance treaties entered into on the basis of the reinsurance policy adopted by the Company and previously described in the Report on Operations.
9 Other changes include the recalculation of the value of the right of use for Via Mecenate No. 90 in Milan following the recalculation of the term of the agreement, and in particular the cancellation of the lease agreement with effect from 30 April 2023.

| Investments | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Investment property | - | - | - |
| Equity investments in subsidiaries, associates and joint ventures | - | 1 | - 1 |
| Financial assets measured at amortised cost | 4,016 | 8,000 | - 3,984 |
| Financial assets measured at fair value through OCI | 181,895 | 141,126 | 40,769 |
| Financial assets measured at fair value through profit or loss | 2,620 | 37,668 | - 35,048 |
| - Financial assets held for trading | - | - | - |
| - Financial assets designated at fair value | - | - | - |
| - Other financial assets compulsorily measured at fair value | 2,620 | 37,668 | 35,048 - |
| Total | 188,531 | 186,795 | 1,736 |
The following tables set out the Group's exposures to debt securities at 31 December 2022, with a breakdown by geographical area and maturity band. In particular, government bonds are broken down into maturities ranging from 0 to 2 years and 2 to 5 years, while corporate bonds fall mainly within the 2- to 5-year range.
In terms of geographical exposure, government debt securities are mainly Italian government bonds, followed by issues by Germany, France and supranational entities. The corporate bond issuers in the portfolio are well-diversified geographically between the United States, the United Kingdom, Spain, Germany and elsewhere.
| Maturity year | 0-2 | 2-5 | > 5 | Total |
|---|---|---|---|---|
| Non-Italian corporate bonds | 4,348 | 15,411 | 2,721 | 22,480 |
| Italian corporate bonds | - | 2,719 | 2,143 | 4,862 |
| Non-Italian government bonds | 30,322 | 25,277 | 412 | 56,011 |
| Italian government bonds | 52,428 | 44,317 | 1,241 | 97,986 |
| Total | 87,098 | 87,724 | 6,517 | 181,339 |
| Maturity year | 0-2 | 2-5 | > 5 | Total |
|---|---|---|---|---|
| Non-Italian corporate bonds | 4,348 | 15,411 | 2,721 | 22,480 |
| US | 4,348 | 957 | - | 5,304 |
| UK | - | 2,514 | 900 | 3,413 |
| ES | - | 1,413 | 1,821 | 3,235 |
| DE | - | 3,231 | - | 3,231 |
| FR | - | 3,041 | - | 3,041 |
| NL | - | 1,768 | - | 1,768 |
| BE | - | 1,092 | - | 1,092 |
| AT | - | 964 | - | 964 |
| CZ | - | 430 | - | 430 |
| Italian corporate bonds | - | 2,719 | 2,143 | 4,862 |
| IT | - | 2,719 | 2,143 | 4,862 |
| Non-Italian government bonds | 30,322 | 25,277 | 412 | 56,011 |
| GE | 14,517 | 2,716 | - | 17,233 |
| FR | 6,880 | 3,724 | - | 10,605 |
| SNAT | 684 | 8,165 | - | 8,849 |
| SP | 991 | 6,508 | - | 7,498 |
| BE | 7,250 | - | - | 7,250 |
| NE | - | 4,164 | - | 4,164 |
| CL | - | - | 412 | 412 |
| Italian government bonds | 52,428 | 44,317 | 1,241 | 97,986 |
| IT | 52,428 | 44,317 | 1,241 | 97,986 |
The tables relating to exposure by separate rating for government bonds and corporate bonds are shown below.

| Government bonds | Total |
|---|---|
| AAA | 27,437 |
| AA | 20,663 |
| A | 7,911 |
| BBB | 97,986 |
| Totale | 153,997 |
| Corporate bonds | Total |
| AA | 957 |
| A | 10,112 |
| BBB | 16,274 |
| Totale | 27,342 |
This category includes financial assets held to collect contractual cash flows, the terms of which give rise to cash flows on specified dates that are solely payments of capital and interest on the principal amount outstanding.
The amount of €4,016,000 refers to deposits in escrow accounts designed to secure the obligations assumed by the sellers of Elba Assicurazioni S.p.A. shares to pay any compensation:
Financial assets measured at fair value through other comprehensive income totalled €181,895,000 (€141,126,000 at 31 December 2021), increasing by €40,769,000, essentially reflecting a different asset allocation compared with the end of the previous year.
This item mainly includes Italian and foreign government bonds, Italian and foreign corporate bonds and other listed fixedincome securities that have passed the SPPI test, amounting to €181,339,000. The bonds in the portfolio are all investment grade securities and therefore all allocated to Stage 1 for the purposes of determining the ECL (expected credit loss); the statement of financial position ECL component relating to these instruments amounts to a total of €38,000.
The item also includes a 10% equity investment in Mangrovia Blockchain Solutions S.r.l., acquired in the first half of 2022 for €1,112,000. As it is strategic, the Group has decided to designate this investment at fair value through other comprehensive income. This equity investment is allocated to Stage 3, and following qualitative and quantitative assessments, it was decided to write down the equity investment by 50% (€556,000) at 31 December 2022.
| Financial assets measured at fair value through profit or loss | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Listed shares - |
- | - | - |
| Debt securities held for trading - |
- | - | - |
| Equity investments - |
- | - | - |
| Total financial assets held for trading | - | - | - |
| - Investment property | - | - | - |
| - Listed debt securities held in regulated markets | - | - | - |
| - Time deposits | - | - | - |
| - Unlisted equity securities measured at fair value | - | - | - |
| Total financial assets at fair value | - | - | - |
| Units in UCIs - |
2,620 | 37,668 | -35,048 |
Financial assets measured at fair value through profit or loss

| Total other financial assets compulsorily measured at fair value | 2,620 | 37,668 | -35,048 |
|---|---|---|---|
| Total | 2,620 | 37,668 | -35,048 |
At 31 December 2022, the amount of €2,620,000 (€37,668,000 at 31 December 2021) is exclusively attributable to financial assets compulsorily measured at fair value, which exclusively comprises mutual fund units held by the Group. There are no financial assets designated at fair value or financial assets held for trading in the portfolio. The item shows a decrease of €35,048,000, mainly due to a change in asset allocation to favour medium-/long-term investments, mainly the type of bonds that can be readily sold off.
No derivative transactions were carried out during the year.
| Miscellaneous receivables | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Receivables deriving from direct insurance operations | 40,303 | 12,827 | 27,476 |
| Receivables deriving from reinsurance operations | 969 | 87 | 882 |
| Other receivables | 11,583 | 9,068 | 2,515 |
| Total | 52,855 | 21,982 | 30,873 |
At 31 December 2022, miscellaneous receivables amounted to €52,855,000 (€21,982,000 at 31 December 2021), representing an increase of €30,873,000.
The nature of the receivables, their amount and the collection of a large portion limit the Group's related credit risk.
Receivables from policyholders at 31 December 2021, amounting to €8,827,000, gross of the provision for doubtful accounts, were collected during 2022 in the amount of €7,145,000, with €1,353,000 cancelled, and were still in arrears by €329,000 at 31 December 2022. The latter were fully written down by the relative provision for doubtful accounts. Receivables from policyholders at 31 December 2022, amounting to €36,439,000, reflected the marked growth in the insurance portfolio during the year and, in particular, the performance of policies written, mainly concentrated in December, a period in which there are many renewals in the specialty lines.
The item also includes receivables from intermediaries totalling €3,864,000 (€4,855,000 at 31 December 2021) and mainly consists of remittances relating to December 2022, almost all of which were collected in early 2023. Their gross amount of €4,163,000 was reduced by the provision for doubtful accounts for agents and brokers of €299,000.
Receivables relating to reinsurance relationships totalled €969,000 (€87,000 at 31 December 2021).
Other receivables of €11,83,000 (€9,068,000 at 31 December 2021) refer to:
| Other assets | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Non-current assets or disposal groups held for sale | - | - | - |
| Deferred acquisition costs | - | - | - |
| Deferred tax assets | - | - | - |
| Current tax assets | 5,394 | - | 5,394 |

| Other assets | 2,134 | 2,428 | -294 |
|---|---|---|---|
| Total | 7,528 | 2,428 | 5,100 |
Other assets refer to:
| Cash and cash equivalents | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Cash and cash equivalents | 4,654 | 12,396 | -7,741 |
| Total | 4,654 | 12,396 | -7,741 |
Cash and cash equivalents showed a balance of €4,654,000 at 31 December 2022 (€12,396,000 at 31 December 2021). This item consists exclusively of bank current accounts and cash.
| Shareholders' equity | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Capital | 6,680 | 23,055 | -16,375 |
| Other equity instruments | - | - | - |
| Capital reserves | 170 | 207,045 | -206,875 |
| Earnings reserves and other equity reserves | 215,870 | 6,462 | 209,408 |
| (Own shares) | -1,247 | - | -1,247 |
| Reserve for net foreign exchange gains/losses | - | - | - |
| Gains or losses on financial assets measured at fair value through OCI | -6,687 | -67 | -6,620 |
| Other gains or losses recognised directly in equity | -3,470 | -4,175 | 705 |
| Profit (loss) for the year attributable to the Group | 5,316 | -13,842 | 19,158 |
| Total shareholders' equity attributable to the Group | 216,632 | 218,478 | -1,846 |
| Capital and reserves - non-controlling interests | - | - | - |
| Gains or losses recognised directly in equity | - | - | - |
| Profit (loss) for the year attributable to non-controlling interests | - | - | - |
| Total shareholders' equity attributable to non-controlling interests | - | - | - |
| Total | 216,632 | 218,478 | -1,846 |
At 31 December 2022, the subscribed and paid-up share capital was €6,680,000, consisting of 24,619,985 ordinary shares and 710.00 special shares convertible into ordinary shares, subject to the conditions laid down in Article 5.8 of the Articles of Association.
As at 31 December 2022, the Group holds 140,953 own shares amounting to €1,247,000 (approximately 0.573% of the share capital, consisting solely of ordinary shares). The Group did not sell any own shares during the year.
The "Other gains or losses recognised directly in equity" item amounted to €3,470,000 and related to the reclassification to shareholders' equity of the €4,160,000 listing costs incurred by REVO, the €151,000 adjustment to the severance indemnity provision pursuant to IAS 19 and the €539,000 adjustment arising from the application of IFRS 2 relating to the portion of fair value in the three-year incentive plan.

In the first half of 2022, the Company announced a plan to allot bonus ordinary shares, named the "2022-2024 Performance Share Plan" (the "Plan"), reserved for the Chief Executive Officer and employees of the Company who perform significant roles or functions and for which an action is justified that will strengthen their loyalty with a view to creating value.
The Plan was approved by the Company's Shareholders' Meeting of 4 April 2022.
The allotment of shares is subject to verification by the Board of Directors, for the year ending 31 December 2024, of a consolidated Solvency II Ratio in excess of 130%.
The number of shares to which each beneficiary is entitled will depend on the number of rights allotted to each beneficiary, the level of performance targets achieved by the Company as defined in the Plan rules and the weighting attributed to individual targets.
Beneficiaries will be required to hold 50% of the shares received in each tranche for at least one year from the allotment date.
Gains or losses on financial assets measured at fair value through comprehensive income amounted to €6,683,000, and related to IFRS 9 adjustments.
The following table sets out the reconciliation of Group shareholders' equity:
| Capital and reserves |
Result for the period |
Shareholders' equity |
|
|---|---|---|---|
| Balances of the Parent Company, REVO | 218,426 | -7,282 | 211,143 |
| IAS/IFRS Parent Company adjustment | - | - | - |
| - 2021 IAS/IFRS adjustment | 52 | - | - |
| - Own shares | -1,247 | - | -1,247 |
| - Valuation of securities portfolio under IFRS 9 | -9,066 | 7,770 | -1,296 |
| - Valuation of net technical provisions under IFRS 4 | - | 1,386 | 1,386 |
| - VoBA amortisation | - | -3,909 | - |
| - Valuation of severance indemnity and agency severance indemnity provisions | 240 | 692 | - |
| - Property under IFRS 16 | - | -383 | - |
| - LTI | 779 | -779 | - |
| - Write-off of improvements to third-party assets | - | 91 | - |
| - Reclassification of Mangrovia write-down | -556 | 556 | - |
| - Reversal of amortisation of calculated intangible value (CIV) of goodwill | - | 8,904 | - |
| - Tax effects related to the above consolidation adjustments | 2,688 | -1,709 | 980 |
| IAS/IFRS balances of Parent Company | 211,315 | 5,338 | 216,653 |
| Elimination of carrying amount of consolidated equity investments: | - | - | - |
| - Local GAAP results achieved by investee Revo Underwriting | - | -22 | -22 |
| Shareholders' equity and profit attributable to the Group | 211,315 | 5,316 | 216,632 |
| Shareholders' equity and profit attributable to non-controlling interests | - | - | - |
| Shareholders' equity and consolidated profit | 211,315 | 5,316 | 216,632 |
Basic earnings per share was calculated by dividing the net profit attributable to the Group by the weighted average number of ordinary shares outstanding during the period.
| (amounts in euro) | 31.12.2022 |
|---|---|
| Profit for the year | 5,316,143 |
| Weighted average no. of shares | 22,436,317 |
| Average earnings per share | 0.24 |
Diluted earnings per share reflects any dilutive effect of potential ordinary shares.
| (amounts in euro) | 31.12.2022 |
|---|---|
| Profit for the year | 5,316,143 |
| Weighted average no. of shares | 27,109,444 |
| Diluted earnings per share | 0.20 |

No dividends were distributed during 2022.
| Provisions | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Provisions | 3,175 | 4,701 | -1,526 |
| Total | 3,175 | 4,701 | -1,526 |
At 31 December 2022, the item includes provisions for future risks in the amount of €3,175,000, all relating to the subsidiary, REVO Insurance. Specifically, the item includes €2,856,000 for future risks deriving from potential terminations of agency relationships existing at the reporting date (the agency severance indemnity provision). In application of IAS 37, a provision of €120,000 was recognised for an insurance contingent liability associated with the
Suretyship class and associated with a court order related to a counterfeit suretyship policy. Accordingly, it was decided, as a precaution, to set aside a portion of the disputed amount and €200,000 for a non-insurance contingent liability.
The agency severance indemnity provision, as well as benefiting from a review of the mandate agreements with the new agencies following the change of ownership, was also specifically analysed during 2022, in order to determine and maintain in the financial statements the portion pertaining to the Company, which is not covered by appropriate indemnity. As a result of these considerations, the provision was subjected to a valuation that, according to market practice, took into consideration the portion covered by the relevant indemnity if the agent terminates its mandate.
| Technical provisions | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Premium reserve | 107,325 | 74,453 | 32,872 |
| Profit-sharing reserve | 58 | - | 58 |
| Claims reserve | 32,691 | 22,551 | 10,140 |
| Total | 140,074 | 97,004 | 43,070 |
The item "Premium reserve for direct insurance risks" amounted to €107,325,000 (€74,453,000 at 31 December 2021, +44.2%). This amount was calculated using the pro-rata temporis method. For the Suretyship class, the unearned premiums reserve is supplemented in accordance with ISVAP Regulation No. 16/2008.
For the purposes of the consolidated financial statements, in accordance with the requirements of IFRS 4, the additional suretyship reserve was calculated for contracts still live at the valuation date.
The table sets out the breakdown of the premium reserve by class:
| Premium reserve | 31.12.2022 | 31.12.2021 | Change | |
|---|---|---|---|---|
| 1 | Accident | 657 | 113 | 544 |
| 2 | Sickness | 7 | - | 7 |
| 5 | Aviation hull | 66 | - | 66 |
| 6 | Marine hull (sea, lake and river and canal vessels) | 859 | - | 859 |
| 7 | Goods in transit | 1,110 | - | 1,110 |
| 8 | Fire and natural forces | 8,660 | 401 | 8,259 |
| 9 | Other damage to property | 10,971 | 10,196 | 775 |
| 11 | Aviation liability | 24 | - | 24 |
| 12 | Marine liability (sea, lake and river and canal vessels) | 22 | - | 22 |
| 13 | General liability | 12,576 | 2,789 | 9,787 |
| 14 | Credit | 82 | - | 82 |
| 15 | Suretyship | 72,064 | 60,949 | 11,115 |
| 16 | Financial loss | 222 | - | 222 |
| 18 | Assistance | 5 | 5 | - |

| Total | 107,325 | 74,453 | 32,872 |
|---|---|---|---|
The claims reserves for direct insurance risks amounted to €32,691,000, up by €10,140,000 compared with 31 December 2021 (+45.0%). The provision for this amount is intended to cover future payments relating to claims, direct expenses and settlement expenses.
The claims reserve also includes the reserve for claims reported late (IBNR), amounting to €1,640,000, created to cover claims incurred but not reported at the end of the year, which reflect, following the change of management, a policy aimed at greater internal prudence in reserving. The amount provisioned was also determined on the basis of the historical values recorded in previous years by means of numerical and average cost projections for each reporting class. The following table sets out the breakdown of the claims reserve by class:
| Claims reserve | 31.12.2022 | 31.12.2021 | Change | |
|---|---|---|---|---|
| 1 | Accident | 82 | 29 | 53 |
| 2 | Sickness | - | - | - |
| 5 | Aviation hull | - | - | - |
| 6 | Marine hull (sea, lake and river and canal vessels) | 888 | - | 888 |
| 7 | Goods in transit | 503 | - | 503 |
| 8 | Fire and natural forces | 1,365 | 101 | 1,264 |
| 9 | Other damage to property | 4,304 | 1,905 | 2,399 |
| 11 | Aviation liability | - | - | - |
| 12 | Marine liability (sea, lake and river and canal vessels) | - | - | - |
| 13 | General liability | 6,675 | 2,530 | 4,145 |
| 14 | Credit | - | - | - |
| 15 | Suretyship | 18,875 | 17,986 | 889 |
| 16 | Financial loss | - | - | - |
| 18 | Assistance | - | - | - |
| Total | 32,691 | 22,551 | 10,140 |
The total claims reserve has been broken down by duration in proportion to the expected cash flows for each time interval in question. The total excludes reserves relating to indirect settlement expenses of €537,000 and the reserves for amounts to be recovered of €5,316,000.
| Maturity | Direct amount |
|---|---|
| up to 1 year | 13,635 |
| 2 to 5 years | 17,323 |
| 6 to 10 years | 5,823 |
| 11 to 20 years | 690 |
| over 20 years | - |
| Total | 37,470 |
The table below shows the trend in cumulative claims paid per year of occurrence, including the amount paid and direct settlement costs and excluding indirect settlement costs.
Cumulative claims paid
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 20 | 65 | 821 | 3,217 | 3,807 | 4,346 | 6,194 | 8,021 | 7,290 | 7,426 | 8,905 | 6,528 | 6,945 | 7,123 | 70,708 |
| 1 | 23 | 893 | 1,566 | 4,858 | 7,296 | 7,608 | 9,817 | 14,660 | 9,928 | 10,035 | 19,066 | 9,545 | 8,521 | 103,816 | |
| 2 | 63 | 1,042 | 1,631 | 4,929 | 7,926 | 8,313 | 10,426 | 14,984 | 10,521 | 10,311 | 19,689 | 10,353 | 100,188 | ||
| 3 | 79 | 1,090 | 1,692 | 5,041 | 8,103 | 8,483 | 10,588 | 15,693 | 10,769 | 11,683 | 20,542 | 93,763 | |||
| 4 | 82 | 1,095 | 1,797 | 5,125 | 8,431 | 8,731 | 10,913 | 15,874 | 11,043 | 13,875 | 76,966 | ||||
| 5 | 82 | 1,219 | 1,838 | 5,223 | 9,082 | 9,184 | 11,858 | 16,073 | 12,354 | 66,913 | |||||
| 6 | 82 | 1,228 | 1,879 | 5,612 | 9,689 | 9,300 | 12,078 | 16,122 | 55,990 | ||||||
| 7 | 82 | 1,228 | 1,919 | 5,664 | 9,969 | 9,494 | 13,005 | 41,361 | |||||||
| 8 | 82 | 1,228 | 2,006 | 5,756 | 10,335 | 9,812 | 29,219 | ||||||||
| 9 | 82 | 1,229 | 2,020 | 5,939 | 10,484 | 19,754 |

| 10 | 82 | 1,232 | 2,047 | 5,948 | 9,309 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | 87 | 1,242 | 2,081 | 3,410 | ||||||
| 12 | 87 | 1,249 | 1,336 | |||||||
| 13 | 87 | 87 | ||||||||
| Total | 1,020 14,040 21,297 57,312 85,122 75,271 84,879 101,427 61,905 53,330 68,202 26,426 15,466 7,123 672,820 |
The difference between the final cost and the cumulative payments recorded in calendar year 2022 produces the claims reserve recognised in the statement of financial position according to the year. The reserve shown in the statement of financial position is obtained by adding to the above reserve a residual portion of €1,640,000 relating to the IBNR reserve, €537,000 to the reserve for indirect settlement expenses and €5,316,000 to the reserve for amounts to be recovered, set out in total in the table below.
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 41 | 739 | 742 | 3,093 | 4,260 | 4,737 | 5,597 | 8,612 | 6,612 | 7,057 | 14,339 | 7,063 | 8,876 | 12,024 | 83,792 |
| 1 | 37 | 117 | 344 | 1,334 | 1,789 | 2,013 | 2,074 | 4,283 | 3,719 | 2,932 | 4,837 | 4,091 | 8,092 | 35,662 | |
| 2 | 7 | 42 | 93 | 1,239 | 1,486 | 1,703 | 1,930 | 4,130 | 2,934 | 2,103 | 3,072 | 4,161 | 22,900 | ||
| 3 | 4 | 2 | 110 | 1,286 | 1,542 | 1,199 | 1,662 | 3,261 | 2,675 | 1,952 | 3,376 | 17,069 | |||
| 4 | - | 2 | 47 | 1,290 | 1,332 | 841 | 1,988 | 3,091 | 1,870 | 2,071 | 12,532 | ||||
| 5 | - | 19 | 81 | 1,271 | 1,159 | 390 | 1,252 | 2,316 | 1,345 | 7,833 | |||||
| 6 | - | 17 | 74 | 345 | 659 | 331 | 2,469 | 2,307 | 6,202 | ||||||
| 7 | - | 30 | 85 | 281 | 598 | 356 | 1,695 | 3,045 | |||||||
| 8 | - | 37 | 8 | 167 | 328 | 288 | 828 | ||||||||
| 9 | 8 | 31 | 6 | 58 | 347 | 450 | |||||||||
| 10 | 3 | 31 | 6 | 85 | 125 | ||||||||||
| 11 | - | 30 | 5 | 35 | |||||||||||
| 12 | - | 34 | 34 | ||||||||||||
| 13 | - | - | |||||||||||||
| Total | 100 | 1,131 | 1,601 | 10,449 | 13,500 | 11,858 | 18,667 | 28,000 | 19,155 | 16,115 | 25,624 | 15,315 | 16,968 | 12,024 | 190,507 |
| Cumulative | 87 | 1,249 | 2,081 | 5,948 | 10,484 | 9,812 | 13,005 | 16,122 | 12,354 | 13,875 | 20,542 | 10,353 | 8,521 | 7,123 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserve | - | 34 | 5 | 85 | 347 | 288 | 1,695 | 2,307 | 1,345 | 2,071 | 3,376 | 4,161 | 8,092 | 12,024 | 35,830 |
| IBNR reserve | 1,640 |
|---|---|
| Reserve for indirect settlement expenses | 537 |
| Reserve for amounts to be recovered | -5,316 |
| Total reserve | 32,691 |
| Financial liabilities | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Financial liabilities measured at fair value through profit or loss | - | - | - |
| Financial liabilities held for trading | - | - | - |
| Financial liabilities designated at fair value | - | - | - |
| Financial liabilities measured at amortised cost | 16,048 | 2,568 | 13,480 |
| Total | 16,048 | 2,568 | 13,480 |
At 31 December 2022, financial liabilities amounted to €16,048,000. This amount corresponds to deposits received from reinsurers of €1,600,000 (€1,252,000 31 December 2021) and are consequent to the reinsurance treaties in progress. This item also includes the adjustment of lease liabilities, pursuant to IFRS 16, which amounted to €14,448,000 at 31 December 2022 (€1,316,000 at 31 December 2021) and includes lease liabilities for:
The amount also includes lease liabilities for company cars.
| Payables | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Payables deriving from direct insurance operations | - | - | - |
| Payables deriving from reinsurance operations | 9,061 | 791 | 8,270 |
| Other payables | 22,553 | 24,362 | -1,809 |
| Total | 31,613 | 25,152 | 6,461 |
Payables deriving from reinsurance operations amounted to €9,061,000 (€791,000 at 31 December 2021) and reflected the new agreements entered into on the basis of the reinsurance policy described in the Report on Operations in these financial statements, as well as the increase in volume of business generated.
The item "Other payables" amounted to €22,553,000, including:
| Other liabilities | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Liabilities of disposal groups held for sale | - | - | - |
| Deferred tax liabilities | 336 | 3,931 | -3,595 |
| Current tax liabilities | - | 888 | -888 |
| Other liabilities | 8,004 | 1,738 | 6,266 |
| Total | 8,340 | 6,557 | 1,783 |
Pursuant to accounting standard IAS 12.74, deferred tax assets and liabilities have been offset, as they relate to the same type of tax.

Deferred tax liabilities of €336,000 (€3,931,000 at 31 December 2021) refer to net deferred taxes deriving from temporary differences generated by the application of Purchase Price Allocation and other temporary differences generated by the application of international accounting standards.
Other liabilities amounted to €8,004,000 and refer to:

As also indicated in the section entitled "Report on Operations" in this financial statements file, following the completion of the acquisition, as of 30 November 2021, of Elba Assicurazioni S.p.A. by REVO S.p.A., the 2021 consolidated income statement data, presented in the schedules below, exclusively show the insurance business developed after completion of the acquisition transaction and therefore only in the month of December 2021; therefore the numerical comparison between the two years is not material.
For this reason and solely for the purposes of incorporating qualitative comments on the evolution of technical insurance management items, the following table provides a summary of the comparison between the technical items recorded by the Group in 2022 and the data for the entire 2021 financial year of Elba Assicurazioni S.p.A.
| Technical data | 31.12.2022 | 31.12.2021 |
|---|---|---|
| Gross premiums written | 131,388 | 77,526 |
| Change in gross premium reserve | -32,871 | -7,203 |
| Premiums ceded | -53,823 | -31,590 |
| Change in ceded premium reserve | 12,011 | 2,493 |
| Net premiums | 56,704 | 41,227 |
| Claims paid | 16,170 | 13,845 |
| Claims paid ceded | -6,223 | -6,392 |
| Recoveries | -5,915 | -6,389 |
| Recoveries ceded | 2,936 | 3,171 |
| Change in gross claims reserve | 11,755 | 3,317 |
| Change in ceded claims reserve | -3,906 | -1,258 |
| Change in recoveries reserve | -1,615 | -804 |
| Change in ceded recoveries reserve | 807 | 411 |
| Net claims-related expenses | 14,010 | 5,901 |
| Acquisition commissions | 30,705 | 18,110 |
| Other acquisition expenses | 10,656 | 6,629 |
| Commissions received from reinsurers | -26,197 | -18,732 |
| Other administrative expenses | 17,877 | 6,791 |
| Other direct technical income and expenses | 1,096 | 2,362 |
| Other technical income and expenses ceded | 166 | -564 |
| Net loss ratio | 24.7% | 14.3% |
| Net combined ratio | 85.5% | 49.7% |
| Net adjusted combined ratio | 78.8% | 47.8% |
As set out in detail in the Report on Operations in this financial statements file, it should be recalled that the adjusted operating profit for the period is €13,879,000 and the adjusted net profit is €10,753,000.
| Net premiums | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Gross premiums earned | 98,517 | 7,103 | 91,414 |
| Premiums ceded to reinsurance during the year | -41,812 | -2,603 | -39,209 |
| Total | 56,705 | 4,500 | 52,204 |
The Group's net premiums amounted to €56,704,000, comprising €98,517,000 in gross premiums earned and €41,812,000 in premiums ceded to reinsurance.

There was a significant increase in gross premiums written (+69.5% compared with 31 December 2021)10, due to:
During the period there was a significant increase not only in Suretyship (+22.7% compared with 2021), which remained the main class during the year, but also in other classes historically managed by the Company (Other damage to property, General liability and Fire), mainly due to the impetus provided by the expansion of the product range and the new intermediation agreements signed in 2022.
At the end of the year, the insurance portfolio was more diversified, with an impact on total gross premiums written in the Suretyship class of 55.7% (77.0% at 31 December 2021), due to the shift towards the other classes, the percentage of which increased from 23.0% at 31 December 2021 to 44.3% at 31 December 2022.
For further comments on the performance of production in 2022, please see the relevant section of the Report on Operations.
| Income and expenses deriving from financial instruments measured at fair value through profit or loss |
31.12.202 2 |
31.12.202 1 |
Chang e |
|---|---|---|---|
| Income and expenses deriving from financial instruments measured at fair value through profit or loss |
-172 | -63 | -109 |
| Total | -172 | -63 | -109 |
Income and expenses deriving from financial instruments measured at fair value through profit or loss shows a negative balance (of €172,000) due to financial expenses relating to instruments in the Group's portfolio.
The Group does not have any equity investments in subsidiaries, associates or joint ventures.
| Income deriving from other financial instruments and investment property | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Interest income | 3,416 | 42 | 3,374 |
| Other income | - | - | - |
| Realised profit | 304 | - | 304 |
| Profit on valuation | - | - | - |
| Total | 3,720 | 42 | 3,678 |
Income deriving from other financial instruments and investment property amounts to €3,720,000 and comprises interest income of €3,416,000 and realised profits of €304,000.
10 The percentage was obtained from a comparison with the technical data presented in the introduction to Part D ("Information on the income statement") of this file. Net retained premiums amounted to €77,565,000 at 31 December 2022 (€45,937,000 at 31 December 2021).

| Other revenues | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Other revenues | 2,018 | 3 | 2,015 |
| Total | 2,018 | 3 | 2,015 |
Other revenues at 31 December amounted to €2,018,000. This item includes:
| Net claims-related expenses | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Amounts paid and change in technical provisions | -20,395 | -1,315 | -19,080 |
| Reinsurers' share | 6,386 | 331 | 6,054 |
| Total | -14,010 | -984 | -13,026 |
Claims-related expenses at 31 December 2022 amounted to €20,395,000 gross of reinsurance and €14,010,000 net of reinsurance.
Claims-related expenses increased, mainly reflecting the increase in the claims reserve of €7,848,000 and, to a lesser extent, higher claims paid of €2,496,000.
At 31 December 2022, the new management strengthened the claims reserve, setting aside a greater IBNR of €1,640,000 compared with 2021, with €192,000 ceded to reinsurance, and implementing a more prudent reserving policy.
In particular, there was an increase in the claims reserve due to ten claims relating to cover taken out in previous years (two relating to Class 9-Other damage to property of €705,000, three relating to Class 13-General liability of €912,000 and five relating to Class 15-Suretyship of €665,000), with a total negative impact of €2,281,000 net of reinsurance, and four claims relating to policies taken out in 2022 with a net impact of €821,000 (one relating to Class 13-General liability of €314,000, one to Class 8-Fire of €171,000 and two relating to Class 6-Marine hull of €336,000).
The technical performance of the Suretyship class was once again extremely profitable in 2022, thanks to the particular attention that the Company devotes to customer lending and the assessment of risks in the underwriting phase. The ratio, gross of reinsurance, of claims paid and reserved, net of recoveries, to earned premiums, was 12.5%, and 13.1% net of reinsurance, compared with 13.9%11 at 31 December 2021.
Net claims for the year increased by €530,000 compared with 31 December 2021, due to the increase in claims paid and reserved (€693,000) versus the positive change in recoveries (€163,000).
In the other non-life insurance classes, the ratio, gross of reinsurance, of claims paid and reserved net of recoveries (including an IBNR provision of €1,640,000, up from €450,000 in 2021) to earned premiums was 34.9% overall (18.6% at 31 December 2021).
11 The percentage was obtained using the technical data presented in the introduction to Part D ("Information on the income statement") of this file.

The overall ratio of claims to premiums in the other classes, net of reinsurance, was 40.5%, compared with 15.2% in 2021. The increase in this ratio in 2022 was mainly due to the following trends:
| Expenses deriving from other financial instruments and investment property | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Interest expense | -1,562 | -152 | -1,410 |
| Other expenses | - | - | - |
| Realised losses | -239 | -2 | -237 |
| Valuation losses | -38 | -112 | 74 |
| Total | -1,839 | -266 | -1,573 |
Expenses deriving from other financial instruments amounted to €1,839,000 and include:
| Operating expenses | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Commissions and other acquisition expenses | -15,164 | -1,116 | -14,048 |
| Investment management expenses | -172 | - | -172 |
| Other administrative expenses | -17,877 | -12,651 | -5,226 |
| Total | -33,213 | -13,767 | -19,446 |
Total commissions and other acquisition expenses, net of commissions received from reinsurers, were €15,164,000 and break down as follows:

Investment management expenses at 31 December 2022 amounted to €171,000, corresponding to indirectly attributable costs, mainly relating to staff assigned to investment management.
Other administrative expenses of €17,877,000 (€12,651,000 at 31 December 2021), the increase in which relates in particular to the increase in payroll expenses due to the recruitment plan for the launch of the Company's development project (an increase of €4,018,000), the costs of listing on the Euronext market of the Milan Stock Exchange and other oneoff expenses of €2,864,000, consultancy costs of €1,226,000 (mainly related to the adoption of the new IFRS 17 accounting standard), additional costs for EDP (electronic data processing) services of €750,000 and other expenses of €1,464,000, due to the growth in business, as well as the various projects launched during the year (e.g. legal and notarial expenses, fees for Directors, Statutory Auditors and the External Auditor, advertising, telephone expenses, etc.). This item also includes €150,000 for the valuations of other long-term employee benefits pursuant to IAS 19 and €778,000 for LTI pursuant to IFRS 2.
| Other costs | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Other costs | -7,998 | -1,406 | -6,592 |
| Total | -7,998 | -1,406 | -6,592 |
Other costs include:

| Taxes | 31.12.2022 | 31.12.2021 | Change |
|---|---|---|---|
| Taxes | 103 | -1,900 | 2,003 |
| Total | 103 | -1,900 | 2,003 |
Taxes have been accounted for in accordance with current tax provisions on an accruals basis.
Prepaid taxes are duly adjusted taking into account the temporary differences between the recorded asset values and the corresponding values recognised for tax purposes.
The value at 31 December 2022, of €103,000, decreased compared with the same period a year earlier due to the negative result recorded at year-end by the Parent Company, which recorded a positive amount of €1,805,000 in taxes, and by the Subsidiary for an amount of €7,000, and was influenced by a tax effect of €1,709,000 resulting from the adjustments made in accordance with the IAS/IFRS conversion.
The following table sets out the reconciliation between the tax rate and the effective rate:
| Effect of increases or (decreases) compared with the ordinary rate | 31.12.2022 | ||
|---|---|---|---|
| IRES | |||
| a | Result before tax | 5,213 | |
| a' | IRES rate | 24% | |
| Expected IRES for the current year | 1,251 | ||
| Expected tax increase | |||
| Multi-year commissions | 10,049 | ||
| Change in net claims reserve | 5,886 | ||
| Allocation to productivity premium | 1,620 | ||
| Amortisation of goodwill | 8,904 | ||
| Other increases | 1,115 | ||
| b | Total increase | 27,574 | |
| c | Total expected tax increase | 6,618 | |
| Expected tax decrease | |||
| Multi-year commissions | 8,455 | ||
| Change in net claims reserve | 2,180 | ||
| Other decreases | 818 | ||
| d | Total decrease | 11,453 | |
| e | Total expected tax decrease | 2,749 | |
| Tax losses | 5,678 | ||
| ACE (Support for Economic Growth scheme) | 871 | ||
| d' | Total other decreases | 6,550 | |
| e' | Total other decreases for IAS/IFRS adjustments | 5,545 | |
| Total other expected tax decreases | 2,903 | ||
| f =a+b-d-d'-e' | IRES taxable base | 9,238 | |
| g=f x a' | IRES for the current year | 2,217 | |
| h= g/a | Effective IRES rate | 42.53% | |
| IRAP | |||
| i | Technical result | 7,396 | |
| i' | IRAP rate | 6.82% | |
| Expected IRAP for the current year | 504 | ||
| Expected tax increase | |||
| Non-deductible payroll costs | 2,097 | ||
| Other administrative expenses | 1,741 | ||
| other increases | 157 | ||
| l | Total increase | 3,994 | |
| m | Total expected tax increase | 272 | |
| Expected tax decrease | |||

| Deduction for certain employees (employee tax wedge) | |||
|---|---|---|---|
| Amortisation of intangible operating assets | 1,375 | ||
| Other decreases | 132 | ||
| n | Total decrease | 1,507 | |
| Total other changes for IAS/IFRS adjustments | 5,545 | ||
| o | Total expected tax decrease | 481 | |
| p=i+l-n | IRAP tax base | 4,338 | |
| q=p x i' | IRAP for the current year | 296 | |
| r= q/i | Effective IRAP rate | 4.00% | |
| Summary | |||
| a | Result before tax | 5,213 | |
| s=g+q | IRES and IRAP for the current year | 2513 | |
| t=s/a | Total tax rate for the year (current IRES + IRAP) | 48.21% | |
| u=a'+i' | theoretical rate (IRES + IRAP) | 30.82% | |
| v | Prepaid taxes 2022 | -5,577 | |
| v' | Prepaid taxes 2021 | 2,961 | |
| v'' (v-v') | Balance of prepaid taxes for temporary differences | -2,616 | |
| y=s+v'' | Taxes for the year including prepaid tax effect | -103 | |
| z=y/a | Effective tax rate for the year (including previous prepaid tax effect) | -1.98% |
The following table summarises the data relating to the deferred tax assets and liabilities recognised in the financial statements, based on the nature of the temporary differences that generated them:
| 31.12.2022 | |||
|---|---|---|---|
| Prepaid taxes | Temporary differences | Tax effect | |
| IRES | Multi-year commissions | 9,398 | 2,255 |
| IRES | Change in net claims reserve | 6,545 | 1,571 |
| IRES | Costs deferred by one year only | 756 | 181 |
| IRES | Non-deductible portion of receivables write-downs | 299 | 72 |
| IRES | Productivity premium | 1,620 | 389 |
| IRES | REVO 2021 tax loss | 5,171 | 1,241 |
| IRES | Difference on valuation of ELBA securities due to merger | -878 | -211 |
| IRES | Valuation of securities under IFRS 9 | -1234 | 296 |
| IRES | Valuation of technical provisions under IFRS 4 | 11440 | - 2,746 |
| IRES | Valuation of leases under IFRS 16 | -475 | 114 |
| IRES | Valuation of severance indemnity and agency severance indemnity | -262 | 63 |
| IRES | VoBA/Leasehold improvements | 8835 | - 2,120 |
| IRES | |||
| IRES | Total deferred tax assets - IRES | 41,215 | 1,105 |
| IRAP | Non-deductible portion of receivables write-downs | 413 | 28 |
| IRAP | Difference on valuation of ELBA securities due to merger | -878 | -60 |
| IRES | Valuation of securities under IFRS 9 | -1234 | 84 |
| IRAP | Valuation of technical provisions under IFRS 4 | 11440 | - 780 |
| IRAP | Valuation of leases under IFRS 16 | -475 | 32 |
| IRAP | Valuation of severance indemnity and agency severance indemnity | -262 | 18 |
| IRAP | VoBA/Leasehold improvements | 8835 | - 603 |
| IRAP | Total deferred tax assets - IRAP | 17839 | -1280 |
| Adjustment for prepaid taxes in previous years | - 161 |
||
| Total deferred tax assets - IRES and IRAP | 59,053 | -336 |
The temporary differences that generated the prepaid taxes, set out in the table above, are the same as those recorded in previous years, with the exception of the REVO tax loss and the difference on the valuation of ELBA securities. Due to the reverse merger between REVO and ELBA, which had retroactive effect as of 1 January 2022, the latter's financial investments were revalued at market value on that date, generating a positive difference of €878,000 (higher values deriving from the allocation of the merger deficit).
This resulted in a mismatch between the carrying amount and the tax value of the securities. To avoid any difference between accounting and tax values, the Company has opted to apply the IRES and IRAP substitute tax, achieving tax recognition of the higher values recognised in the financial statements. To all intents and purposes, therefore, this is a substitute tax payable which can be paid through the tax return for fiscal year 2022.
With regard to the tax loss reported in the above table, please note that on 19 May 2022 the Company submitted an application to the Italian Revenue Agency specifically requesting the lifting of limits on the carry over of tax losses envisaged in Article 172, paragraph 7, of Presidential Decree No. 917 of 22 December 1986 ("TUIR"), in relation to the reverse merger for the incorporation of the parent company, Revo S.p.A., into Elba Assicurazioni S.p.A.
On 28 November 2022, the Italian Revenue Agency issued a favourable opinion.
The accounting standard IFRS 13 regulates the measurement of fair value and the related disclosure.
The breakdown of the measurement at fair value and the amount of financial investments and liabilities recorded in the financial statements is provided below.
| 31.12.2022 | 31.12.2021 | |||
|---|---|---|---|---|
| Carrying amounts and fair values | Carrying amount | Fair value | Carrying amount | Fair value |
| Investment property | - | - | - | - |
| Equity investments in subsidiaries, associates and joint ventures | - | - | 1 | 1 |
| Financial assets measured at amortised cost | 4,016 | 4,016 | 8,000 | 8,000 |
| Financial assets measured at FV through OCI | 181,895 | 181,895 | 141,126 | 141,126 |
| Financial assets measured at FV through profit or loss | 2,620 | 2,620 | 37,667 | 37,667 |
| Cash and cash equivalents | - | - | - | - |
| Total investments | 188,531 | 188,531 | 186,794 | 186,794 |
| Financial liabilities measured at fair value through profit or loss | - | - | - | - |
| Financial liabilities measured at amortised cost | 16,048 | 16,048 | 2,568 | 2,568 |
| Total financial liabilities | 16,048 | 16,048 | 2,568 | 2,568 |
As can be seen from the table above, there are no financial investments or liabilities whose carrying amount differs from measurement at fair value.

In accordance with Article 2427, paragraph 13 of the Italian Civil Code, as a result of the reverse merger of Elba Assicurazioni S.p.A. and the listing on the Euronext market of the Milan Stock Exchange, exceptional costs of €2,864,000 were incurred during the year.
On 4 April 2022, the Company's Shareholders' Meeting also approved a performance share plan called the "2022-2024 Performance Share Plan" (hereinafter, the "Plan"), the rules of which were drawn up and approved by the Board of Directors of REVO Insurance S.p.A. on 26 May 2022.
The Plan is a valid tool for retaining and motivating individuals who play a key role in achieving the Group's objectives, and for aligning the interests of key company resources with those of other stakeholders, with a view to long-term sustainable development.
In particular, the Plan sets out the following main terms and conditions:
Overall, the shares allotted and accruing to service the Plan amount to approximately 602,000, for a total value of €4,674,000, of which €779,000 has already been recognised in the income statement.
At 31 December 2022, the Company did not record any contingent liabilities, purchase commitments or guarantees. Although not reported in the statement of financial position, for some insurance contracts written by the Parent Company, collateral guarantees were obtained (mainly pledges on life policies and bank guarantees) to be used, in the event of enforcement of the policy, to ensure the recovery of any sums paid to policyholders.
The table below shows the carrying amount of right-of-use assets at year-end for each class of underlying asset.

| Item | Amount |
|---|---|
| Property | 12,440 |
| Company cars | 246 |
| Total | 12,687 |
Lease liabilities at 31 December 2022 amounted to xxx and are recognised under financial liabilities measured at amortised cost in the statement of financial position.
The table below sets out the breakdown of lease liabilities by maturity:
| Maturity | Amount |
|---|---|
| maturing within one year | 330 |
| 2-3 years | 300 |
| over 5 years | 13,905 |
| Total | 14,535 |
| Item | Amount |
|---|---|
| depreciation of rights of use | 783 |
| lease interest expense | 62 |
| other costs | 137 |
| Total | 981 |
The "Other costs" item relates to the recalculation of the amounts relating to the leasing of Via Mecenate 90 in Milan, following the Parent Company's decision to move the operational headquarters to another location and the consequent termination of the lease agreement with effect from 30 April 2023.
In 2022 the average Group headcount was 128 (18 executives, 107 employees and 4 contractors), with a total cost of €13,418,000. In the previous year, the average headcount was 86 (10 executives, 74 employees and 2 contractors), with a total cost of €6,519,000.
At 31 December 2022, the Company's Board of Directors consisted of a chairman, a chief executive officer and five directors. The remuneration payable for 2022 amounts to €512,000 (€570,000 at 31 December 2021).
The Company's Board of Statutory Auditors consists of a chairman, three standing auditors and two alternate auditors; the fees payable for 2022 amount to €132,000 (€154,000 at 31 December 2021).
The following table, pursuant to Article 149 of the Issuers' Regulation, sets out the fees accrued during the year for services provided by the External Auditor and entities in its network (the amounts shown do not include expenses, Consob contributions and VAT):
| Type of service | Company | Remuneration |
|---|---|---|
| Statutory audit | KPMG S.p.A. | 194 |
| Solvency II review | KPMG S.p.A. | 65 |
| Certification services | KPMG S.p.A. | 18 |
| Activities related to the listing: | ||
| - Full audit |
KPMG S.p.A. | 87 |
| - Limited audit |
KPMG S.p.A. | 23 |
| - Comfort letters |
KPMG S.p.A. | 230 |


| - | ||
|---|---|---|
| - Certification services |
KPMG S.p.A. | 5 |
| - Other services |
KPMG S.p.A. | 90 |
| 712 |
Milan, 9th March 2023 REVO Insurance S.p.A. Chief Executive Officer (Alberto Minali) that

93 TABLE OF CONTENTS | Schedules attached to the notes to the financial statements


| Non-life operations Life operations |
Equity interests | Other | Cross-sectoral eliminations | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
||
| 1 INTANGIBLE ASSETS | 92,116,507 | 90,599,696 | 0 | 20,696 | 11,231 | 92,127,738 | 90,620,392 | ||||||
| 2 TANGIBLE ASSETS | 14,448,189 | 344,147 | 0 | 535 | 0 | 14,448,189 | 344,682 | ||||||
| 3 REINSURERS' SHARE OF TECHNICAL PROVISIONS | 55,736,807 | 39,894,995 | 0 | 0 | 0 | 55,736,807 | 39,894,995 | ||||||
| 4 INVESTMENTS | 188,530,889 122,342,623 | 0 64,451,774 | 0 | 188,530,889 186,794,397 | |||||||||
| 4.1 Investment property | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 4.2 Equity investments in subsidiaries, associates and joint ventures | 0 | 0 | 0 | 1,000 | 0 | 0 | 1,000 | ||||||
| 4.3 Financial assets measured at amortised cost | 4,016,029 | 0 | 0 | 8,000,016 | 0 | 4,016,029 | 8,000,016 | ||||||
| 4.4 Financial assets measured at fair value through OCI | 181,895,099 121,595,998 | 19,529,748 | 0 | 181,895,099 141,125,746 | |||||||||
| 4.5 Financial assets measured at fair value through profit or loss | 2,619,761 | 746,625 | 0 36,921,010 | 0 | 2,619,761 | 37,667,635 | |||||||
| 5 MISCELLANEOUS RECEIVABLES | 52,930,836 | 21,978,306 | 0 | 3,241 | -75,263 | 0 | 52,855,573 | 21,981,547 | |||||
| 6 OTHER ASSETS | 7,526,920 | 2,256,724 | 171,451 | 1,186 | 7,528,106 | 2,428,175 | |||||||
| 6.1 Deferred acquisition costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 6.2 Other assets | 7,526,920 | 2,256,724 | 171,451 | 1,186 | 7,528,106 | 2,428,175 | |||||||
| 7 CASH AND CASH EQUIVALENTS | 4,444,450 | 4,007,045 | 0 | 8,388,801 | 210,023 | 4,654,473 | 12,395,846 | ||||||
| TOTAL ASSETS | 415,734,598 281,423,230 | 0 73,036,498 | 147,177 | 0 | 415,881,775 354,459,728 | ||||||||
| 1 SHAREHOLDERS' EQUITY | 216,631,562 218,477,836 | ||||||||||||
| 2 | 3,175,588 | 4,700,710 | 0 | 0 | 0 | 3,175,588 | 4,700,710 | ||||||
| 3 TECHNICAL PROVISIONS | 140,073,526 | 97,004,143 | 0 | 0 | 0 | 140,073,526 | 97,004,143 | ||||||
| 4 FINANCIAL LIABILITIES | 16,047,787 | 2,567,991 | 0 | 0 | 0 | 16,047,787 | 2,567,991 | ||||||
| 4.1 Financial liabilities measured at fair value through profit or loss | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 4.2 Financial liabilities measured at amortised cost | 16,047,787 | 2,567,991 | 0 | 0 | 0 | 16,047,787 | 2,567,991 | ||||||
| 5 PAYABLES | 31,594,480 | 7,133,127 | 0 18,019,062 | 18,940 | 0 | 31,613,420 | 25,152,189 | ||||||
| 6 OTHER LIABILITIES | 8,339,813 | 6,556,860 | 0 | 80 | 8,339,893 | 6,556,860 | |||||||
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 415,881,776 354,459,729 |

| Non-life operations | Life operations Equity interests |
Other | Cross-sectoral eliminations |
Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.20 22 |
Total 31.12.20 21 |
Total 31.12. 2022 |
Total 31.12.2021 |
Total 31.12.20 22 |
Total 31.12.20 21 |
Total 31.12.202 2 |
Total 31.12. 2021 |
Total 31.12.202 2 |
Total 31.12.202 1 |
||
| 1.1 | Net premiums | 56,704,347 | 4,499,682 | 0 | 0 | 0 | 56,704,347 | 4,499,682 | |||||
| 1.1.1 Gross premiums earned | 98,516,646 | 7,102,713 | 0 | 0 | 0 | 98,516,646 | 7,102,713 | ||||||
| 1.1.2 Premiums ceded to reinsurance during the year | -41,812,299 | -2,603,031 | 0 | 0 | 0 | - 41,812,299 |
-2,603,031 | ||||||
| 1.2 | Commission income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Income and expenses deriving from financial instruments measured at fv |
|||||||||||||
| 1.3 | through profit or loss | -171,676 | 543 | 0 | -63,370 | 0 | -171,676 | -62,827 | |||||
| 1.3bi s |
Reclassification according to the overlay approach (*) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| 1.4 | Income deriving from equity investments in subsidiaries, associates and joint ventures |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| 1.5 | Income deriving from other financial instruments and investment property |
3,720,495 | 40,367 | 0 | 1,143 | 0 | 3,720,495 | 41,510 | |||||
| 1.6 | Other revenues | 2,046,593 | 1,740 | 0 | 1,241 | -28,183 | 0 | 2,018,410 | 2,981 | ||||
| 1 | TOTAL REVENUES AND INCOME | 62,299,759 | 4,542,332 | 0 | 0 | -60,986 | -28,183 | 0 | 0 | 0 62,271,576 | 4,481,346 | ||
| 2.1 | Net claims-related expenses | -14,009,631 | -983,805 | 0 | 0 | 0 | 0 | - 14,009,631 |
-983,805 | ||||
| 2.1.1 Amounts paid and change in technical provisions | -20,395,208 | -1,314,885 | 0 | 0 | 0 | - 20,395,208 |
-1,314,885 | ||||||
| 2.1.2 Reinsurers' share | 6,385,577 | 331,080 | 0 | 0 | 0 | 6,385,577 | 331,080 | ||||||
| 2.2 | Commission expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Expenses deriving from equity investments in subsidiaries, associates and j.v. |
|||||||||||||
| 2.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Expenses deriving from other financial instruments and investment property |
|||||||||||||
| 2.4 | -1,838,640 | -249,175 | 0 | -17,209 | 0 | -1,838,640 - |
-266,384 - |
||||||
| 2.5 | Operating expenses | -33,213,603 | -2,421,324 | 0 | -11,345,979 | 834 | 0 | 33,212,769 | 13,767,303 | ||||
| 2.6 | Other costs | -7,996,004 | -637,116 | 0 | -768,867 | -1,815 | -7,997,819 | -1,405,983 | |||||
| 2 | TOTAL COSTS AND EXPENSES | -57,057,878 | -4,291,420 | 0 -12,132,055 | -981 | 0 | - 57,058,859 |
- 16,423,475 |
|||||
| PROFIT (LOSS) FOR THE YEAR BEFORE TAX (*) Only for companies that decide to adopt the overlay approach |
5,241,881 | 250,912 | 0 | 0 | 0 -12,193,041 | -29,164 | 0 | 0 | 0 | 5,212,717 | - 11,942,129 |
pursuant to paragraph 35B of IFRS 4
(**) To be stated, including by adding several columns, in relation to
the materiality of the activity carried out in the various sectors

| Name | Country of registered office |
Country of operational headquarters (5) |
Method (1) |
Activity (2) |
% Direct equity investment |
% 100% interest (3) |
% Availability of votes at the ordinary shareholders' meeting (4) |
% consolidation |
|---|---|---|---|---|---|---|---|---|
| Revo Underwriting S.r.l. | ITALY | ITALY | F | 11 | 100% | 100% | 100% | 100% |
(1) Consolidation method: Full consolidation=F, Proportional consolidation=P, Full consolidation with single management=U
(2) 1=Italian ins.; 2=EU ins.; 3=third-country ins.; 4=insurance holding companies; 4.1=mixed financial holding companies; 5=EU reins.; 6=third-country reins.; 7=banks; 8=asset
management companies; 9=misc. holding companies; 10=property; 11=other
(3) is the product of investment relationships relating to all the companies that, located along the investment chain, may be interposed between the company that prepares the consolidated financial statements and the company in question. If the latter is directly owned by several subsidiaries, the individual products must be added
(4) total percentage availability of votes at ordinary shareholders' meetings if other than direct or indirect equity investment
(5) this information is required only if the country of the operational headquarters is not the same as the country of the registered office

Scope of consolidation: equity investments in companies with material non-controlling interests
| Summary financial data | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | % non controlling interests |
% availability of votes at the ordinary shareholders' meeting to non controlling interests |
Consolidated profit (loss) attributable to non-controlling interests |
Shareholders' equity attributable to non-controlling interests |
Total assets |
Investments | Technical provisions |
Financial liabilities |
Shareholders' equity |
Profit (loss) for the year |
Dividends distributed to non controlling interests |
Gross premiums written |

| Name | Country of registere d office |
Country of operational headquarters (5) |
Activity (1) |
Type (2) |
% Direct equity investment |
% 100% interest (3) |
% Availability of votes at the ordinary shareholders' meeting (4) |
Carrying amount |
|---|---|---|---|---|---|---|---|---|
(1) 1=Italian ins.; 2=EU ins.; 3=third-country ins.; 4=insurance holding companies; 4.1=mixed financial holding companies; 5=EU reins.; 6=third-country reins.; 7=banks; 8=asset management companies; 9=misc. holding companies; 10=property; 11=other
(2) a=subsidiaries (IFRS 10); b=associates (IAS28); c=joint ventures (IFRS 11); indicate with an asterisk (*) companies classified as held for sale in accordance with IFRS 5 and provide a legend at the end of the schedule
(3) is the product of investment relationships relating to all the companies that, located along the investment chain, may be interposed between the company that prepares the consolidated financial statements and the company in question. If the latter is directly owned by several subsidiaries, the individual products must be added
(4) total percentage availability of votes at ordinary shareholders' meetings if other than direct or indirect equity investment
(5) this information is required only if the country of the operational headquarters is not the same as the country of the registered office
| At cost | At restated value or fair value | Total carrying amount | |
|---|---|---|---|
| Investment property | |||
| Other property | 13,972,722 | 13,972,722 | |
| Other tangible assets | 475,467 | 475,467 | |
| Other intangible assets | 17,805,028 | 17,805,028 |

| Direct business | Indirect business | Total carrying amount | ||||||
|---|---|---|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |||
| Non-life reserves | 55,736,807 39,894,995 | 0 | 0 55,736,807 39,894,995 | |||||
| Premium reserve | 43,152,350 | 30,367,105 | 0 | 43,152,350 | 30,367,105 | |||
| Claims reserve | 12,584,457 | 9,527,890 | 12,584,457 | 9,527,890 | ||||
| Other reserves | 0 | 0 | ||||||
| Life reserves | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reserve for amounts payable | 0 | 0 | ||||||
| Mathematical reserves | 0 | 0 | ||||||
| Technical provisions where the investment risk is borne by policyholders and reserves deriving |
||||||||
| from pension fund management | 0 | 0 | ||||||
| Other reserves | 0 | 0 | ||||||
| Total reinsurers' share of technical provisions | 55,736,807 39,894,995 | 0 | 0 55,736,807 39,894,995 |

| Financial assets measured at amortised cost |
Financial assets measured at fair value through profit or loss | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial assets measured at fair value through OCI |
Financial assets held for trading |
Financial assets designated at fair value |
Other financial assets compulsorily measured at fair value |
Total carrying amount |
|||||||||
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |||
| Equity securities | 556,418 | 556,418 | 0 | ||||||||||
| of which listed securities | 0 | 0 | |||||||||||
| Debt securities | 181,338,681 | 141,125,746 | 181,338,681 | 141,125,746 | |||||||||
| of which listed securities | 181,338,681 | 141,125,746 | 181,338,681 | 141,125,746 | |||||||||
| Units in UCIs | 2,619,761 | 37,667,635 | 2,619,761 | 37,667,635 | |||||||||
| Loans and receivables | |||||||||||||
| from bank customers | 0 | 0 | |||||||||||
| Interbank loans and receivables | 0 | 0 | |||||||||||
| Deposits with ceding undertakings | 0 | 0 | |||||||||||
| Financial assets in | |||||||||||||
| insurance contracts | 0 | 0 | |||||||||||
| Other loans and receivables | 0 | 0 | |||||||||||
| Non-hedging derivatives | 0 | 0 | |||||||||||
| Hedging derivatives | 0 | 0 | |||||||||||
| Other financial investments | 4,016,029 | 8,000,016 | 4,016,029 | 8,000,016 | |||||||||
| Total | 4,016,029 | 8,000,016 181,895,099 141,125,746 | 0 | 0 | 0 | 0 | 2,619,761 37,667,635 188,530,889 186,793,397 |

| Direct business |
Indirect business |
Total carrying amount | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | ||||
| Non-life reserves | 139,941,565 | 97,004,143 | 131,961 | 0 | 140,073,526 | 97,004,143 | |||
| Premium reserve | 107,330,032 | 74,453,175 | 131,961 | 107,461,993 | 74,453,175 | ||||
| Claims reserve | 32,611,533 | 22,550,968 | 32,611,533 | 22,550,968 | |||||
| Other reserves | 0 | 0 | |||||||
| of which reserves allocated following a check on the adequacy of liabilities |
0 | 0 | |||||||
| Life reserves | |||||||||
| Reserve for amounts payable | |||||||||
| Mathematical reserves | |||||||||
| Technical provisions where the investment risk is borne by policyholders and reserves deriving from pension fund management |
|||||||||
| Other reserves | |||||||||
| of which reserves allocated following a check on the adequacy of liabilities |
|||||||||
| of which deferred liabilities to policyholders | |||||||||
| Total technical provisions | 139,941,565 | 97,004,143 | 131,961 | 0 | 140,073,526 | 97,004,143 |
| Financial liabilities measured at fair value through profit or loss |
Financial liabilities measured at | Total carrying amount |
||||||
|---|---|---|---|---|---|---|---|---|
| Financial liabilities held for trading |
Financial liabilities designated at fair value |
amortised cost | ||||||
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | |
| Participating financial instruments | 0 | 0 | ||||||
| Subordinated liabilities | 0 | 0 | ||||||
| Liabilities from financial contracts issued by insurance companies, deriving | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| From contracts where the investment risk is borne by policyholders | 0 | 0 | ||||||
| From pension fund management | 0 | 0 | ||||||
| From other contracts | 0 | 0 | ||||||
| Deposits received from reinsurers | 1,599,677 | 1,251,518 | 1,599,677 | 1,251,518 | ||||
| Financial liabilities in insurance contracts | 0 | 0 | ||||||
| Debt securities issued | 0 | 0 | ||||||
| Payables to bank customers | 0 | 0 | ||||||
| Interbank payables | 0 | 0 | ||||||
| Other loans obtained | 0 | 0 | ||||||
| Non-hedging derivatives | 0 | 0 | ||||||
| Hedging derivatives | 0 | 0 | ||||||
| Misc. financial liabilities | 14,448,110 | 1,316,473 | 14,448,110 | 1,316,473 | ||||
| Total | 0 | 0 | 0 | 0 | 16,047,787 | 2,567,991 16,047,787 | 2,567,991 |

| 31.12.2022 | 31.12.2021 | ||||||
|---|---|---|---|---|---|---|---|
| Gross amount |
reinsurers' share |
Net amount | Gross amount |
reinsurers' share |
Net amount |
||
| Non-life operations | |||||||
| NET PREMIUMS | 98,516,646 | -41,812,299 56,704,347 | 7,102,714 | -2,603,032 | 4,499,682 | ||
| a Premiums written |
131,388,093 | -53,822,910 | 77,565,183 | 8,824,591 | -3,210,183 | 5,614,408 | |
| b Change in premium reserve |
-32,871,447 | 12,010,611 | -20,860,836 | -1,721,877 | 607,151 | -1,114,726 | |
| NET CLAIMS-RELATED EXPENSES | -20,395,208 | 6,385,578 -14,009,630 | -1,314,886 | -331,081 | -983,805 | ||
| a Amounts paid |
-16,170,285 | 6,223,088 | -9,947,197 | -1,814,314 | -828,253 | -986,061 | |
| b Change in the claims reserve |
-11,754,723 | 3,906,304 | -7,848,419 | 116,488 | 308,051 | -191,563 | |
| c Change in recoveries |
7,529,800 | -3,743,814 | 3,785,986 | 382,940 | 189,121 | 193,819 | |
| d Change in other technical provisions |
0 | 0 | 0 | 0 | 0 | 0 | |
| Life operations | |||||||
| NET PREMIUMS | |||||||
| NET CLAIMS-RELATED EXPENSES | |||||||
| a Amounts paid |
|||||||
| b Change in reserve for amounts payable |
|||||||
| c Change in mathematical reserves |
|||||||
| Change in technical provisions where the investment risk is borne by policyholders d and deriving from pension fund management |
e Change in other technical provisions

| Realised profit |
Realised losses |
and realised expenses |
Total income Profit on valuation | Valuation losses | Total income Total income Total income | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest | Other income |
Other expenses |
Valuation gains |
Write backs |
Valuation losses |
Write downs |
and unrealised expenses |
and expenses 31.12. 2022 |
and expenses 31.12. 2021 |
||||
| Investment result | 1,839,303 | 0 | 0 304,084 -239,150 | 1,904,237 | 0 | 0 -171,676 -37,661 | -209,337 | 1,694,900 | -287,701 | ||||
| a Deriving from investment property |
-61,605 | -61,605 | 0 | -61,605 | 0 | ||||||||
| b Deriving from equity investments in subsidiaries, associates and joint ventures | 0 | 0 | 0 | 0 | |||||||||
| c Deriving from financial assets measured at amortised cost |
0 | 0 | 0 | 0 | |||||||||
| d Deriving from financial assets measured at fair value through OCI | 1,900,908 | 304,084 -239,150 | 1,965,842 | -37,661 | -37,661 | 1,928,181 | -224,874 | ||||||
| e Deriving from financial assets held for trading |
0 | 0 | 0 | 0 | |||||||||
| f Deriving from financial assets designated at fair value |
0 | 0 | 0 | 0 | |||||||||
| Deriving from other financial assets g compulsorily measured at fair value |
0 | -171,676 | -171,676 | -171,676 | -62,827 | ||||||||
| Result for misc. receivables | 15,278 | 15,278 | 0 | 15,278 | 0 | ||||||||
| Result for cash and cash equivalents | 0 | 0 | 0 | 0 | |||||||||
| Result for financial liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| a Deriving from financial liabilities held for trading |
0 | 0 | 0 | 0 | |||||||||
| b Deriving from financial liabilities designated at fair value | 0 | 0 | 0 | 0 | |||||||||
| C Deriving from financial liabilities measured at amortised cost | 0 | 0 | 0 | 0 | |||||||||
| Result for payables | 0 | 0 | 0 | 0 | |||||||||
| Total | 1,854,582 | 0 | 0 304,084 -239,150 | 1,919,515 | 0 | 0 | -171,676 -37,661 | -209,337 | 1,710,178 | -287,701 |

| Non-life operations | Life operations | ||||
|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 | 31.12.2022 | 31.12.2021 | ||
| Gross commissions and other acquisition expenses | -41,361,042 | -3,245,096 | |||
| a Acquisition commissions |
-30,704,992 | 552,664 | |||
| b Other acquisition expenses |
-10,656,050 | -3,797,760 | |||
| c | Change in deferred acquisition costs | ||||
| d Collection commissions |
|||||
| Commissions and share of profits received from reinsurers | 26,197,039 | 2,129,064 | |||
| Investment management expenses | -171,687 | 0 | |||
| Other administrative expenses | -17,877,079 | -12,651,271 | |||
| Total | -33,212,769 | -13,767,303 | 0 |
| Charges | Adjustments for reclassification Other changes to the income statement |
Total changes | Taxes | Balance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
Total 31.12.2022 |
Total 31.12.2021 |
|
| Other income not reclassified to the income statement | 1,018,861 -6,034,594 | 0 | 0 | 1,018,861 -6,034,594 | -314,013 | 1,859,862 -3,469,884 -4,174,732 | ||||||
| Reserve deriving from changes in shareholders' equity of investee companies | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Revaluation reserve for intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Revaluation reserve for tangible assets | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Income and expenses relating to non-current assets or disposal groups held for sale | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Actuarial gains and losses and adjustments relating to defined benefit plans | 1,018,861 | -21,272 | 1,018,861 | -21,272 | -314,013 | 6,556 | 690,132 | -14,716 | ||||
| Gains or losses on equity securities designated at fair value through OCI | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Reserve deriving from changes in own creditworthiness on financial liabilities designated at fair value | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other elements | -6,013,322 | 0 | -6,013,322 | 0 | 1,853,306 | -4,160,016 | -4,160,016 | |||||
| Other income to be reclassified to the income statement | -9,560,733 | -96,995 | -8,728 | 0 | 0 | 0 -9,569,461 | -96,995 | 2,949,308 | 29,894 -6,687,254 | -67,101 | ||
| Reserve for net foreign exchange gains/losses | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Gains or losses on financial assets (other than equity securities) measured at fair value through OCI | ||||||||||||
| -9,560,733 | -96,995 | -8,728 | -9,569,461 | -96,995 | 2,949,308 | 29,894 | -6,687,254 | -67,101 | ||||
| Gains or losses on cash flow hedging instruments | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Gains or losses on instruments hedging a net investment in a foreign operation |
0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Reserve deriving from changes in shareholders' equity of investee companies | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Income and expenses relating to non-current assets or disposal groups held for sale | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Reclassification according to the overlay approach (*) | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other elements | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| TOTAL OTHER COMPREHENSIVE INCOME | -8,541,872 | -6,131,589 | -8,728 | 0 | 0 | 0 | -8,550,600 | -6,131,589 | 2,635,295 | 1,889,756 -10,157,138 | -4,241,833 |

Breakdown of reclassified financial assets and effects on the income statement and overall profitability


| Level 1 | Level 2 | Level 3 | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 31.12.2022 | 31.12.2021 31.12.2022 31.12.2021 31.12.2022 31.12.2021 | 31.12.2022 | 31.12.2021 | ||||||
| Assets and liabilities measured at fair value on a recurring basis | |||||||||
| Financial assets measured at fair value through OCI | 181,338,681 141,125,746 | 556,418 | 181,895,099 141,125,746 | ||||||
| Financial assets held for trading | 0 | 0 | 0 | 0 | |||||
| Financial assets measured at fair value through profit or loss | Financial assets designated at fair value | 0 | 0 | 0 | 0 | ||||
| Other financial assets compulsorily measured at fair value | 0 | 37,667,635 | 2,619,761 | 2,619,761 | 37,667,635 | ||||
| Investment property | 0 | 0 | |||||||
| Tangible assets | 0 | 0 | |||||||
| Intangible assets | |||||||||
| Total assets measured at fair value on a recurring basis | 0 | 0 | |||||||
| 0 | 0 | ||||||||
| Financial liabilities measured at fair value through profit or loss | Financial liabilities held for trading | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financial liabilities designated at fair value | 0 | 0 | |||||||
| Total liabilities measured at fair value on a recurring basis | 181,338,681 178,793,381 | 2,619,761 | 556,418 | 184,514,860 178,793,381 | |||||
| Assets and liabilities measured at fair value on a non-recurring basis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Non-current assets or disposal groups held for sale | |||||||||
| Liabilities of disposal groups held for sale |

| Financial assets measured at fair value through profit or loss | Financial liabilities measured at fair value through profit or loss |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Financial assets measured at fair value through OCI |
Financial assets held for trading |
designated at fair value |
Financial assets Other financial assets compulsorily measured at fair value |
Investment property |
Tangible assets |
Intangible assets |
Financial liabilities held for trading |
Financial liabilities designated at fair value |
|
| Opening balance | 0 | ||||||||
| Purchases/issues | 1,112,837 | ||||||||
| Sales/repurchases | |||||||||
| Redemptions | |||||||||
| Profit or loss recognised in the income statement | |||||||||
| - of which valuation gains/losses | |||||||||
| Profit or loss recognised | |||||||||
| in other comprehensive income | |||||||||
| Level 3 transfers | |||||||||
| Transfers to other levels | |||||||||
| Other changes | -556,418 | ||||||||
| Final balance | 556,418 |

| Fair value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carrying amount | Level 1 | Level 2 | Level 3 | Total | ||||||
| Year n | Year n-1 | Year n | Year n-1 | Year n | Year n-1 | Year n | Year n-1 | Year n | Year n-1 | |
| Assets | ||||||||||
| Financial assets measured at amortised cost | ||||||||||
| Equity investments in subsidiaries, associates and joint ventures | ||||||||||
| Investment property | ||||||||||
| Tangible assets | ||||||||||
| Total assets | ||||||||||
| Liabilities | ||||||||||
| Financial liabilities measured at amortised cost |

|--|

Mr Jacopo Tanaglia Mr Alberto Minali Financial Reporting Officer Chief Executive Officer REVO Insurance S.p.A. REVO Insurance S.p.A.
but I .
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.